P

Program


  • Day by day

  • Sessions

  • Timetable

  • Speakers

  • Sponsored

  • Speakers

  • Topics

  • Print

Italian course (ECM)

Pre-congress course

Official Language

English is the official language of the Congress.

CME Accreditation

The scientific programme has been accredited with 24 European CME credits by the European Accreditation Council for Continuing Medical Education;
The Italian sessions by AIGE is accredited for 2.1 italian ECM each

Wednesday 7th March 2018

08:30 Wednesday 7th

Affari 1 Pre-Congress Course 08:30 ￫ 13:30
(Pre-Congress Course) Menstrual cycle disorders: from adolescence to menopause

  • Frederick Naftolin The Hypothalamic-Pituitary-Gonadal Axis: Puberty, Menstrual Cycle Regulation, and Post-Reproductive Life
  • Sarah Berga Hypothalamic amenorrhea
  • Basil Tarlatzis Polycystic ovary syndrome
  • Alessandro D. Genazzani Metabolism, obesity, thinness and reproduction
  • Nick Panay Practical approaches to managing premature ovarian insufficiency

09:00 Wednesday 7th

Sala 226 Assembly 09:00 ￫ 11:00
FISGE Meeting

11:30 Wednesday 7th

Sala 226 Assembly 11:30 ￫ 13:30
FLEG Meeting

15:30 Wednesday 7th

Auditorium Opening Symposium 15:30 ￫ 17:00
Intracrinology: the open door to the future

Chairperson/s: David Archer , Andrea R. Genazzani

  • Fernand Labrie Intracrinology –the exclusive source of sex steroids in postmenopausal women is prasterone
  • Celine Bouchard Healthy and sex steroid-deprived vagina-from preclinical to clinical characteristics
  • Rossella E. Nappi The medical impact of vulvovaginal atrophy /genitourinary syndrome of menopause

17:15 Wednesday 7th

Auditorium Opening Ceremony 17:15 ￫ 18:00

  • The ISGE Executive Committee
    Andrea R. Genazzani,
    Martin Birkhaueser
    Tommaso Simoncini
  • The Scientific Societies and Institutions
    C N Purandare(FIGO) Pitfalls and limitations of current evidence generation,
    John J. Sciarra(ACOG),
    Mary Ann Lumsden (RCOG),
    Alessandro Genazzani (AIGE)

18:00 Wednesday 7th

Auditorium Opening Lecture 18:00 ￫ 18:30
(OL01) for the Bruno Lunenfeld Lecture: RANKL – from bone loss to breast cancer (introduced by Lunenfeld Bruno)

  • Josef M. Penninger RANKL – from bone loss to breast cancer

18:30 Wednesday 7th

Auditorium Opening Lecture 18:30 ￫ 19:00
(OL02) The neurological and immunological transitions of the perimenopause: implications for post menopausal neurodegenerative disease (introduced by Frederick Naftolin)

  • Roberta Brinton Diaz The neurological and immunological transitions of the perimenopause: implications for post menopausal neurodegenerative disease

19:00 Wednesday 7th

Poster Area Poster Session 19:00 ￫ 21:00
From 1 To 176

  • Jose Maria Soares Júnior P1. Evidence that melatonin increases inhibin beta-A and follistatin gene expression pinealectomized rat ovaries
  • Roberta Vicario Is it possible to improve the diagnostic accuracy of salpingosonohisterography?
  • ana maria Muñoz Ledesma SEVERE HYPERCALCEMIA IN PREGNANT WOMEN, SECUNDARY A NEUROENDOCRINE TUMORS
  • Miriam Llano P2. Different secretory pattern of melatonin in obese menopausal women: preliminary results
  • Rodrigo Marcondes P3. Moderate intensity treadmill exercise increases ovulation and modulates genes in the hypothalamus of adult female rats
  • Negina Adkhamova P4. Polymorphism C3420T of the DRD2 gene associated with menstrual flow disorder among the women with hyperprolactinemia
  • Ariadne Araujo P5. Gene expression of small leucine-rich proteoglycans (SLRPS) in lacrimal gland non-pregnant and pregnant with hyperprolactinemia induced metoclopramide
  • Natalia Garcia New therapeutic targets for uterine leiomyosarcoma: Gant61 as a blocker to non-canonical activation of Sonic Hedgehog pathway
  • Osvaldo Araujo Jr P6. Influence of metoclopramide-induced hiperprolactnemia on the epiphyseal plate and type of collagen in the bone tissue of female mice and their offspring after breastfeeding
  • Osvaldo Araujo Júnior P7. Small leucine-rich proteoglycans (slrps) on the epiphyseal plate of the female mice metoclopramide-induced hiperprolactnemia and their offspring
  • Irena Ilovayskaya P8. Recurrent early pregnancy loss as unusual and rare sign of pathological hyperprolactinemia
  • Amanpreet Kalsi P9. Macroprolactinemia: prevalence and etiopathologic associations
  • María Jose García Rubio P10. Spontaneous pregnancy after trans-sphenoidal resection of a microadenoma refractory to medical treatment. A case report.
  • Felipe Serrano P11. Prolactin hyper-response is associated with incidence of herpes in patients with ovulatory dysfunction.
  • Larisa Suturina P12. Prevalence of hyperprolactinemia in unselected urban female population
  • Ana Belen Rodriguez Bujez P13. Which wil be better for the endometrium in ovarian stimulation?
  • Natalia Aganezova P14. Endometrial receptivity in women with a history of reproductive failures
  • Danijel Bursac P15. The role of GABA neurotransmitter in the regulation of the endocervical mucus secretion
  • Jose Maria Júnior P16. Effects of melatonin on steroidogenesis in rat ovarian theca-interstitial cells: relevance to hormone therapy in polycystic ovary syndrome (PCOS)
  • Lara Jessica Murao P17. A Case Report on Catamenial Epilepsy
  • Ricardo Ramirez Orozco P18. Role of adiposity over ERα and ERβ phosphorylation in reproductive women during ovarian cycle
  • Elisabetta Vegeto P19. Pharmacological regulation of estrogen receptors in macrophages: impact for the female reproductive tract
  • Elisabetta Vegeto P20. Sexual differences in macrophage physiology
  • Natasha Meletti P21. Ovarian hypertecosis and hirsutism in adolescence: case report and literature review
  • Marija Miletic P22. Mister XX
  • Cintia Mariel Villegas Rodríguez P23. Effect of hiperandrogenism on the lipid profile on women with polycystic ovary syndrome at the endocrine gynecology clinic of the hospital juárez de méxico
  • Peiqiong Chen P24. Association between serum level of vitamin A and premature ovarian insufficiency in women of reproductive age
  • Edson Ferreira Filho P25. A case of 46,XY gonadal dysgenesis with remaining epididymis mimicking ovotesticular disorder of sexual development
  • Satit Klangsin P26. Agreement of two medical approaches with the expert consensus in identified the causes of primary amenorrhea in Songklanagarind Hospital
  • Cristina Laguna Benetti-Pinto P27. Sleep quality assessment in women with premature ovarian insufficiency using Hormonal Therapy
  • Li Li P28. Rare Copy Number Variants (CNVs) in the Genome of Chinese Female Adolescents with Turner Syndrome
  • Giovana Maffazioli P29. Evaluation of Differences in Clinical Characteristics Between Patients with the Classical Karyotype of Turner Syndrome and Mosaics
  • Sevara Nigmatova P30. Ovarian Function and Pregnancies in Women with Premature Ovarian Failure
  • Marjan Onabi P31. Rare and atypical cases of primary amenorrhea
  • Patrycja Rojewska- Madziała P32. Clinical, biochemical and genetic characterization of a 44- years old patient with primary amenorrhoea- case study of complete androgen insensitivity syndrome
  • Gyuzyal Tabeeva P33. The role of the expression of steroid receptors in ovaries of women with premature ovarian inssuficiency (POI).
  • Sharareh Abdollah P34. Missed Important Facts in diagnosis and treatment of Polycystic Ovarian Syndrome (PCOs)
  • Yulia Absatarova P35. Melatonin as a new pathogenetic factor in the development of anovulation in polycystic ovary syndrome
  • Yulia Absatarova P36. Pathogenetic effects of folate-containing combined oral contraceptive in patients with PCOS
  • CHANTAL AMISI P37. Wrist circumference: a new marker for assessing insulin resistance in sub-saharan african women with polycystic ovary syndrome
  • Mohamed Basly P38. vascular endothelial growth factor antagonist reduces the early onset and the severity of ovarian hyperstimulation syndrome Links
  • Adriana Carbonel P39. Effects of soybean isoflavones in rats model with polycystic ovary syndrome (pcos)
  • Adriana Carbonel P40. Action of melatonin, metformin, clomiphenic citrate in the ovary of rats in permanent estro
  • Sebastião de Medeiros P41. The interrelationship between anthropometric biologic markers of body fat distribution and steroid hormone biosynthesis in polycystic ovary syndrome
  • SHALINI GAINDER P42. Endometrial hyperplasia in infertile pcos women
  • Aleksandra Głowińska P43. Sexual Satisfaction in Women with Polycystic Ovary Syndrome
  • Roya Hosseini P44. Obesity and Insulin resistance in infertile women with polycystic ovary syndrome
  • Sujata Kar P45. 2D & 3D Trans-vaginal sonography to determine cut offs for ovarian volume and follicle number per ovary for the diagnosis of Polycystic ovary syndrome in Indian women.
  • Jasneet Kaur P46. Clinical application of the automated AMH assay for diagnosing PCOS in Indian women
  • Zurqa Khalid P47. TITLE: Circulating biomarkers for the diagnosis of Polycystic Ovarian Syndrome patients: A Meta-analysis
  • Daniela Koleva P48. Serum Visfatin Levels in Women with Polycystic Ovary Syndrome
  • Vilma Kovač P49. Policystic ovarian syndrome (PCOS) patients with higher body mass index (BMI) have significantly lower level of antimullerian hormone (AMH) and lower response on IVF/ICSI treatment
  • Yanglu Li P50. Comparing the risk of adverse pregnancy outcomes of Chinese polycystic ovary syndrome patients with and without anti-androgenic pretreatment
  • Ying li P51. Potential role of MicroRNA-32 on the proliferation of granulosa cells in polycystic ovarian syndrome women
  • Julia Nikolova P52. Serum levels of soluble E-selectin in polycystic ovary syndrome
  • Presiyana Nyagolova P53. Leptin And Galanin-like Peptide (GALP) Levels in Women With Polycystic Ovary Syndrome (PCOS)
  • Emma Öberg P54. Personality factors predicting successful weight loss in polycystic ovary syndrome
  • Maria Orbetzova P55. Serum levels of TNF-α and IL-6 in women with polycystic ovary syndrome
  • Christina Pagkaki P56. Polycystic ovary syndrome as a risk factor for premature ovarian insuffisiency: controversial data
  • Anastasios Potiris P57. Fibrinolytic defects, but not thrombophilic disorders, may be associated with recurrent miscarriages in women with polycystic ovary syndrome
  • Alessia Prati P58. Modulatory effects of D-Chiro-inositol (DCI) plus alpha lipoic acid (ALA) combination on metabolic and hormonal parameters of obese PCOS patients
  • Manuela RUSSU P59. PCOS and obesity as a cause for endometrial carcinoma in very young women – case presentation
  • Ricardo Simoes P60. Analysis of hyaluronic acid in the endometrium of women with polycystic ovary syndrome
  • Ricardo Simões P61. Action of melatonin, metformin, clomiphene citrate in the endometrium of rats in permanent estro
  • Katarzyna Suchta P62. Binge eating disorder in women with polycystic ovary syndrome.
  • Iroda Tojieva P63. Interrelation of paracrine factors and factors of proinflammation in patients with PCOS
  • Maria Helena Tur-Torres P64. Update of insulin resistance in adolescents with polycystic ovary syndrome and its relationship with hyperandrogenism and obesity in Vall Hebron Hospital population
  • DULARI VORA P65. Study to co-relate incidence of ovarian cysts / tumors in patients with bulky ovaries or polycystic ovarian disease (PCOD) and/or obesity
  • Husheng Wang P66. Clinical predictive value of anti-Müllerian hormone in polycystic ovary syndrome
  • Rafał Watrowski P67. Spontaneous life-threatening ovarian hyperstimulation in a patient with severe diabetes and unrecognized polycystic ovarian syndrome
  • Giulia Despini P68. Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients
  • Ivika Jakson P69. Insulin and the Down-regulation of Glucose Transporter 1 in Decidualizing Endometrial Stromal Cells
  • Felipe Serrano P70. Insulin sensitivity and testicular function in a cohort of adult males suspected of being insulin-resistant
  • Milina Tancic-Gajic P71. Insulin resistance in severely obese women after weight loss
  • HACER ALAN DIKMEN P72. The Relationship Between Maternal Obesity and Prenatal Attachment
  • Eleni Armeni P73. Adiposity measures and bone mineral density are associated with ovarian volume after the menopausal transition
  • Aleksandra Atanasova Boshku P74. Serum Sex Hormone Binding Globulin (SHBG) Relation with Different Components of Metabolic Syndrome in Women with Polycystic Ovary Syndrome
  • Livia Dainelli P75. The Short-Term Economic Burden of Gestational Diabetes Mellitus in Italy
  • Mónica Flores-Ramos P76. Is waist-circumference related to anxiety levels in peri and postmenopausal women?
  • Rail Gazizov P77. Identification of metabolic syndrome and overweight among university teachers
  • Roya Hosseini P78. Diagnostic value of pre-gravid body mass index in determining of gestational diabetes mellitus in assisted reproduction technology
  • Sana Menjli P79. Obesity:physiologic changes and challenges during laparoscopy
  • Eliana Nahas P80. Isolated vitamin D supplementation improves the metabolic syndrome risk profile in postmenopausal women: a randomized, double-blind, placebo-controlled trial
  • Nur Nahdiyat P81. The impact of obesity to increase the risk of miscarriage in reproductive women
  • Laura Seco P82. Parental nutrition: methyl donors and nutri-epigenomics.
  • Marianna Torok P83. Gender differences in the biomechanics and vasoreactivity of coronary resistance arteries in exercise induced left ventricular hypertrophy
  • Hasmik Bareghamyan P84. Pregnancy and spontaneous preterm rupture of membranes
  • Hasmik Bareghamyan P85. A clinical case report: PREGNANCY, TETRALOGY OF FALLOT OF THE FETUS AND PREMATURE RUPTURE OF THE MEMBRANES
  • MARIANA GARCIA P86. An extremely rare complication of type 1 diabetes mellitus: Pierre Mauriac syndrome.
  • Charalampos Siristatidis P87. Age at menarche in the prediction of clinical pregnancy and live birth outcomes following Assisted Reproduction Technologies
  • Iryna Tuchkina P88. Optimization of surgical management of adnexal torsion in girls
  • Ksenia Fris P89. Morphofunctional endometrium changes in women with autoimmune thyroid pathology and pregnancy losses.
  • Roya Hosseini P90. Premature Ovarian insufficiency and thyroid Autoimmunity
  • Elena Andreeva P91. Vitamins and microelements at the stage of pre-gravity preparation and during pregnancy in patients with endocrinopathies.
  • Cristina Benetti-Pinto P92. Android fat distribution directly affects thrombin-activatable fibrinolysis inhibitor (TAFI) levels in women with polycystic ovary syndrome
  • Ksenia Fris P93. The expression of paracrine factors in women with autoimmune thyroid diseases and reproductive failures.
  • Alejandro Hernandez P94. 25-hydroxyvitamin-D levels in women attending a private outpatient clinic in Medellín – Colombia, 2013-2014
  • Yumie Ikeda P95. Developing A Smartphone Application for Daily Records of Premenstrual Symptoms: How is it accepted by non-PMS patients?
  • Olga Leshchenko P96. The state of the system of neuroendocrine regulation in women with reproductive disorders and genital tuberculosis
  • Zarkhanim Mammadova P97. Outcomes of gynecologic and endocrinologic disorders among 0-20 years girls in Baku ( Azeraijan)
  • Siripen Ongsupharn P98. The effect of oligomenorrhea and factors affecting metabolic syndrome in Thai postmenopausal women
  • Vesna Salamun P99. GLP-1 Receptor Agonist Liraglutide increased IVF Pregnancy Rates in Obese Women with PCOS and previous poor response to first line reproductive treatments:: a Pilot Randomized Study
  • Polyxeni-Maria Sarli P100. Granulosa cell ovarian tumor and resistance to clomiphene citrate. A case report and review of the literature.
  • Egle Vaiciuliene P101. Quality of Life in Adult Women with Turner Syndrome
  • Jianhong Zhou P102. Change in health-related quality of life in the menopausal transition and its associated factors in Chinese middle-aged women
  • KATARZYNA BŁASZCZAK-ŚWIĄTKIEWICZ P103. Selectivity and biological functionality of new selective modulator of progesterone receptor – novel mesoprogestin and its effect on endometrium proliferation.
  • Alina Busan P104. Non-Contraceptive Benefits of Contraceptives – Retrospective Study in Clinical Hospital of Obstetrics and Gynecology “Prof Dr Panait Sarbu” Bucharest
  • Tatiana Tatarchuk P105. Non-contraceptive benefits of hormonal contraception for Ukrainian military women.
  • Natalia Aganezova P106. Emergency contraception among doctors and people without medical education
  • Klaus Nickisch P107. Contributions to Ulipristals mechanism of action as Emergency Contraceptive Agent
  • JASMINE LALL P108. Comparative study of postplacental cu-t insertion in vaginal and caesarean deliveries
  • Alina Mihaela Busan P109. Determinant Factors in Choosing the Contraceptive Method Based on the Age of Patient
  • Karine Tokhunts P110. Consistent and combined application of dienogest and LNG-IUS to decrease the risk of IUS expulsion
  • MUHAMMAD AZRAI ABU P111. Knowledge, Attitude and Practice towards Intrauterine Contraception Device among Doctors in an Urban City of Malaysia
  • Jean-Michel Foidart P112. Physical tests of the Levosert T-frame and its inserter provide objective parameters that confirm their safety and easiness at insertion
  • Nilson Melo P113. Prevention of unplanned pregnancy through subdermal implant in women users of illicit drugs in the region of cracolandia, São Paulo.
  • Iuliia Naumova P114. Adverse events of Essure® contraception. Analysis in a large cohort of patients.
  • Maria Antonia Obiol P115. Local complications associated with the insertion and removal of Implanon NXT®.
  • nelli nahapetyan P116. Consistent and combined application of dienogest and LNG-IUS to decrease the risk of IUS expulsion
  • Mohd Faizal Ahmad P117. Endometrial thickness and embryo quality in predicting the outcome of icsi and embryo transfer: a retrospective cohort study
  • Shi Yee Chen P118. Does trophectoderm morphology better in predicting euploidy compared to inner cell mass? A retrospective study
  • Ileana Alejandra G. Cantón P119. Effect of Claudin-1 expression on the sperm membrane on the blastocyst rate in euploid embryos
  • IOANNIS GIAKOUMAKIS P120. Importance of serum vitamin d in surrogacy motherhood program and ivf success rates
  • Laura Seco P121. Obesity and embryo development
  • ROBABEH TAHERIPANAH P122. Comparison of Serum and Uterine Flushing Concentrations of Glycodelin on Days 21-23 of Reproductive Cycle among Women with In Vitro Fertilization Failure versus Normal Fertile Women
  • Taisiia Yurchuk P123. Blastomere biopsy of incomplete compacted human morula can improve the embryo cryopreservation outcome
  • Abbas Majdi Seghinsara P124. The role of Ovarian Surface Epithelial Stem Cells (OSESC) in neo-oogenesis and cell therapy
  • EVANGELIA ZAPANTI P125. Interleukin 15 concentrations in follicular fluid and their effect on oocyte maturation in subfertile women undergoing intracytoplasmic sperm injection.
  • Mounir AJINA P126. Comparison of ICSI results in a group of patients with and without oral L-carnitine, acetyl-L-carnitine and nutrients supplementation
  • Agnieszka Dubiel P127. The prevalence of antinuclear antibodies (ANA) in AITD women with history of miscarriage
  • Francisco Sandoval Garcia Travesi P128. The expression of the Claudin family in the testis – a dynamic membrane behavior for sperm formation in patients with infertility
  • MUHAMMAD AZRAI ABU P129. Factors influencing poor prognosis for azoospermic men before intracytoplasmic sperm injection.
  • Karina Cázarez Pérez P130. Dna fragmentation, a nuclear evaluation for sperm production during life years.
  • Ali Gurbuz P131. Medical treatment of İsthmocele with Gonadotropin Releasing Hormone Agonists (GnRHa) before frozen thawed embryo transfer- A preliminary report
  • Fatemehsadat Hoseini P132. A non-randomized controlled trial of oral melatonin supplementation on ATPase 6 gene expression and IVF outcomes in Iranian infertile couples
  • Jehona Luta P133. Pregnancy after hysterosalpingography
  • Zoia Rossokha P134. The shift in emphasis of infertility genetic risk caused by defects in folate related gene polymorphism
  • Charalampos Siristatidis P135. Age of subfertile women and clinical pregnancy outcome following Assisted Reproduction Technologies
  • Deniss Sõritsa P136. Physical activity of infertile women before, during and after in vitro fertilization treatment and its effect on pregnancy outcome
  • Julio Avilés P137. Effect of Tadalafil on endometrial thickness, receptivity in assisted reproduction cycles and its reproductive results
  • Andreea Carp-Veliscu P138. Autologous platelet-rich plasma in endometrial growth: our clinical experience
  • Gabriella Donà P139. Effect of astaxanthin on human sperm capacitation: in vivo and in vitro studies
  • Mariia Mazilina P140. Morula-stage embryo vitrification in cryopreservation cycles: five years of positive experience
  • Diana Mihai P141. Has the ‘freeze-all” strategy a better pregnancy outcome?
  • Marco Noventa 142. Ultrasound- Guided Embryo Transfer: Summary of Evidences to Close the Open Debate and Unlock New Perspectives. Literature Review and Meta-Analysis
  • Ales Sobek P143. Treatment of low oocyte quality in the Czech Republic
  • Vanessa Trindade P144. The use of intravenous lipids emulsion in reproductive medicine: An Experience at Fertilitat – Center of Reproductive Medicine
  • Asiyat Rabadanova P145. Three Dimensional Power Doppler and the efficiency of IVF cycles.
  • Ali Gurbuz P146. Evaluation of dual trigger with combination of gonadotropin releasing hormone agonist and human chorionic gonadotropin in improving oocyte-follicle ratio in normo-responder patients
  • Krzysztof Lukaszuk P147. Novel multiple consecutive stimulation protocol – shortening duration of infertility treatment
  • Manuela Neagu P148. Monoovulation Induction with Aromatase Inhibitors – Retrospective Clinical Study
  • Svetlana Spremovic-Radjenovic P149. Letrozole versus clomiphene as the first-line treatment for anovulatory infertility in women with pcos
  • Siti Nabillah Ab Rahman P150. Right or Left Ovary: Which has better ovarian response? A study of ART outcome in IVF patients in HSNZ Kuala Terengganu, Malaysia.
  • Marta Sestero P151. Ovarian sensitivity index and Follicular Output Rate are good measure of ovarian responsiveness to gonadotrophin stimulation
  • Nasuha Yaacob P152. The Influence of serum estradiol levels on the day of ovulation trigger on assisted reproductive outcome in HSNZ Kuala Terengganu, Malaysia.
  • Yolanda Cabello P153. Establishment of a protocol for severe endometriosis management and ovarian stimulation for IVF treatment. First pregnancies and newborn children.
  • Maria Luisa Gasparri P154. Origin of placental disorders after assisted reproduction: Assisted reproduction itself or Endometriosis as its indication
  • SZE MAN LAW P155. In-vitro fertilization (IVF)/ Intracytoplasmic Insemination (ICSI) Outcomes in Endometriosis- Related Infertility: 8 years Results from an Assisted Reproductive Unit
  • ANA RODRIGUEZ BUJEZ P156. Endometriosis and tubo-ovarian pelvic abscess after oocyte retrieval
  • Yolanda Cabello P157. Proposal of necessary tests for all the patients before Assisted Reproduction Treatments in order to prevent factors that could affect implantation failure, miscarriages or other gestational complications.
  • yu liang P158. The effects of insulin-like growth factor-I on IVF outcome of diminished ovarian reserve
  • ANA RODRIGUEZ BUJEZ P159. Five years on fertility preservation public program
  • JOSÉ SOARES-JR P160. Melatonin antiproliferative effects in rats frozen-thawed ovarian autografts: preliminary findings in a scaffold-based delivery
  • José Soares-Jr P161. Melatonin effects on ovarian tissue cryopreserved transplantation
  • Xiadi Huang P162. Association of coenzyme Q10 with premature ovarian insufficiency
  • Chunming Li P163. Pyrethroid Pesticide Exposure and Risk of Primary Ovarian Insufficiency in Chinese Women
  • shiba abdollah P164. Evaluation of serumic progesterone`s level with pregnancy out come in frozen embryo transfer
  • ROSOLINO CATANIA P165. The association of Anti-thyroid Peroxidase Antibodies and anti-Phospholipid antibodies in recurrent miscarriage A literature rewiew.
  • Dmytro Konkov P166. The preventive strategy of cervical incompetency
  • Adriana RAMALHO P167. Interstitial Ectopic Pregnancy in High Risk Maternity in the Amazon Region: Case Report
  • Tejal Poddar P168. Double trouble: a rare case of bilateral ectopic pregnancy following intracytoplasmic sperm injection
  • Ana Azcárraga Sapena P169. Comparison of cesarean section rate and demographic risk factors between 2008-2016 at clinic university hospital of valencia
  • Mira Bittár P170. Reasons for planned, urgent and immediate cesarean sections and actions to prevent unnecessary cesareans
  • STEFANIA TRIUNFO P171. Health care cost analysis for deliveries according to the maternal age classes in an university hospital setting: a five-years retrospective cohort study
  • Hasmik Bareghamyan P172. Pregnancy and Tetralogy of Fallot
  • Aziza Chemima P173. Iniencéphalie: Diagnostic amtenatal d’une pathologie rare et revue de la littérature
  • Zaklina Jurisic P174. Advance 3D Ultrasound techniques in detection of cleft palate from 12-18th week of pregnancy
  • Adriana RIBEIRO RAMALHO P175. Malaria vivax in pregnant attended in a school hospital of amazon region
  • Andrea Sepulveda P176. Obstructed Hemivagina and Ipsilateral Renal Anomaly Syndrome (OHVIRA) in pregnancy: A CASE REPORT

19:05 Wednesday 7th

Poster Area Poster Session 19:05 ￫ 21:00
From 177 To 365

  • Yauheniya Tsikhanovich P177. Doppler studies in patients with chronic venous disease and prediction of neonatal hypoxia.
  • Nurezwana Elias P178. A case report: Fatal outcome of cerebral venous sinus thrombosis with cerebral hemorrhage due to antithrombin III deficiency during early pregnancy
  • Hasmik Bareghamyan P179. Pregnancy, severe oligohydramnios and tetralogy of fallot of the fetus
  • emilio diaz P180. Exosomal miRNA profile in gestational diabetes – Potential role in placental metabolism
  • Ziwen Jiang P181. Translocation of placental target pullulan based nanoparticle drug delivery system in an in vitro placental
  • Hasmik Bareghamyan P182. Pregnancy and HLA incompatibility
  • Hasmik Bareghamyan P183. Pequliarity of pregnancy and labor in women with hla incompatibility
  • Gagik Beglaryan P184. Hla incompatibility and pregnancy
  • Anastasiya Novikova P185. Pregnancy and intrauterine infection in adolescents
  • Adriana RIBEIRO RAMALHO P186. Immune Thrombocytopenic Purpura in Pregnant Women in the Amazon Region: Case Report
  • Elena Costa P187. Change in prevalence of Gestational Diabetes and obstetric complications when applying IADPSG screening criteria in a Belgian French population
  • Elena Khazova P188. Two seasons of the level of calcidiol in pregnant women of St. Petersburg.
  • Tatyana Novikova P189. Obstetric-gynecological risk factors for osteopenia in the postpartum period
  • Manuela Cristina Russu P190. Pregnancy outcome in the dual endocrinopathy diabetes mellitus and hypothyroidism. 5 years retrospective study
  • Florije Spahija P191. 30 doses of platelets that saved a case of immune-thrombocytopenia
  • Irina E. Zazerskaya P192. Vitamin D deficiency and pregnancy outcomes.
  • Alejandra Elizalde Cremonte P193. Current state of gestational diabetes (dg) in our maternity. Corrientes. Argentina. 2017
  • Chung-Yi Li P194. A nationwide case-control study of gestational diabetes mellitus in association with air pollution in Taiwan
  • Manuela Stefana Neagu P195. Metformin improves the obstetrical outcome of women with gestational diabetes
  • Imre Tormasi P196. Association of pathological tyrosine isoforms with parameters of hematopoiesis in hyperfiltrating physiological pregnant women
  • Paweł Bartnik P197. Attendance to antenatal classes reduces perinatal pain and fear in primiparous women.
  • Patricija Kasilovska P198. Unexpected pregnancy-is it a big problem?
  • Jehona Luta P199. The importance of information for Rh-immunization
  • Nor azila Mohd Nafiah P200. Women with hyperemesis gravidarum: does acupressure wristband helps in reducing severity?
  • JOSE RANGEL PADILLA P201. Depressive syndrome secondary to spontaneous abortion and its correlation with the clinical history of the patients treated in the gynecology and obstetrics service at Dr. Dario Fernandez Fierro Hospital Mexico City
  • Magdalena Smyka P202. Obstructive sleep apnea is a risk factor of preterm delivery
  • Merita Vuniqi-Krasniqi P203. Adolescent pregnancy in Kosovo
  • Pinar Yalcin Bahat P204. Episiotomy approach to the women of postpartum persistent migrain cases
  • Andrea Sepulveda P205. Cervical cerclage of rescue in the management of cervical incompetence. Experience of luis tisne brousee hospital
  • Umida Ashurova P206. Associations of vascular tone genes polymorphisms in pregnancy-induced hypertension among Uzbek women: a case-control study.
  • Ofelia Bettikher P207. Association between fasting serum C-peptide level, obesity, preeclampsia and gestational diabetes
  • Karol Charkiewicz P208. Syndecan 4, galectin 2 and DR3 as a novel factors in pathways of mild preeclampsia – protein macroarray screening.
  • Karol Charkiewicz P209. Sphingolipids screening in plasma of women with preeclampsia.
  • EDNEA DE OLIVEIRA P210. HELLP Syndrome: Case Report
  • Sabine Enengl P211. The sFlt-1/PlGF ratio and its predictive value concerning time to delivery in patients with preeclampsia- Preliminary Data
  • Feriha fatima Khidri P212. VEGF gene polymorphisms and serum VEGF levels in preeclampsia
  • Galina Khlestova P213. Disturbancies of the balance of vasoconstrictors and vasodilatators in the maternal blood plasma in the genesis of preeclampsia
  • Dmytro Konkov P214. The modern hemodynamic features of predictive diagnosis of preeclampsia
  • Tetiana Loskutova P215. Metabolism and lipids peroxidation in women with preeclampsia
  • Natalia Pasman Natalia Pasman P216. Pasman N.M., Chumanova O.V., Voronina E.N., Philipenko M.L., Drobinskaya A.N. Assessment of a role of hemostasis system genes polymorphism and the genes which are responsible for formation of an endothelium dysfunction in development of gestational complications
  • Sahadete Shala P217. Hypertension induced by pregnancy after In Vitro Fertilization and Embryo Transfer
  • Charalampos Siristatidis P218. The role of interleukins in preeclampsia: a comprehensive review
  • sapiyat ibragimova P219. The role of gene polymorphisms of the renin-angiotensin in the etiology of early and late preeclampsia actuality
  • Danijel Bursac P220. Acute pulmonary oedema in pregnant women with the use of beta-agonists
  • Shqipe Fetiu -Salihu P221. Pregnancy after In Vitro Fertilization and cervical cerclage
  • Richard Mayer P222. Should all patients with congenital heart disease, WHO group III or higher, be advised against pregnancy?
  • YOSHINO SAITO P223. Whether do Japanese pregnancy women know the effect of sodium and potassium to blood pressure or not.
  • Andrea Sepulveda P224. Hemoperitoneum in ambdominal pregnancy: a case report
  • Manijeh Mehdinejad P225. Study of bacteriuria in pregnant women and determination of their antibiotic susceptibility patterns
  • Alexandra Ursache P226. Ultrasound parameters to evaluate HIV positive pregnant women
  • Georg Gruessenberger P227. Birth mode in twin-pregnancies- Outcome based on the Apgar-Score 5 minutes after delivery
  • Ija Lisovaja P228. Hyperreactio luteinalis in twin pregnancy, a case report.
  • Mohd Faizal Ahmad P229. Amniotomy and early oxytocin infusion versus amniotomy and delayed oxytocin infusion in nulliparous women: a randomised controlled trial
  • Anna Thorbiörnson P230. Oral versus vaginal prostaglandin for labor induction
  • Alexandra Ursache P231. The utility of ultrasound examination in the surveillance of misodel induced labor
  • Kistaman Dzhamalutdinova P232. Immunohistochemical characteristic of stem cells markers in foci of nodular and diffuse adenomyosis.
  • Faina Guseinova P233. Efficacy of transplantation of bone marrow stromal mesenchymal cells in the therapy of female genital tuberculosis in rabbits (experimental-morphological study)
  • Li Ling P234. Effects of human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation on chemotherapy-induced primary ovarian insufficiency in rats
  • Elena Usoltseva P235. Endometrial stem cells homing to injured and intact endometrium
  • Olena Gnatko P236. Ovarian reserve in adolescent girls born with intrauterine growth retardation
  • Nigar Kamilova P237. Assessment of risk impacts on the development of obesity in adolescent girls
  • Anastasiya Novikova P238. Gynecological disorders on the background of stress during puberty
  • Iryna Tuchkina P239. Urgent conditions in pediatric and adolescent gynecology
  • Chiara Cassani P240. Sexual function and distress in natural menopausal women and breast cancer survivors with signs and symptoms of vulvo-vaginal atrophy/genito-urinary syndrome (vva/gsm).
  • Juan Du P241. Effects of Oral Contraceptives on Sexual Function in PCOS Patients
  • Lara Tiranini P242. Exploring the relationship among sexual function, cues for sexual desire and psychological general well-being in a sample of healthy women seeking hormonal contraception.
  • Aziza Chemima P243. Hormonal disorders among Adolescents
  • Miho Egawa P244. Development of a smartphone application system for symptom-recording to manage premenstrual syndrome and its clinical use
  • Kazuko HIYOSHI P245. Brain Bold Signal-Based Blood Flow Tracking by fMRI with menstrual cycle on healthy women.
  • Hisayo Okayama P246. The relevance of Sense of Coherence to Premenstrual Dysphoric Disorder and depression state of young women in Japan
  • Jelena Otasevic P247. Lower levels of serum vitamin D are in correlation with reduced ovarian reserve
  • Vira Pyrohova P248. Combined hyperproliferative processes of the reproductive organs and vitamin d deficiency
  • Patimat Khirieva P249. The condition of the endometrium in women of reproductive age with intrauterine adhesions.
  • Yinmei Dai P250. Diagnostic and therapy effect of hysyeroscopic technology in abnormal uterine bleeding
  • YU SUN P251. FIGO classification system (PALM-COEIN) for causes of chronic abnormal uterine bleeding in Chinese women of reproductive age
  • Tze Tein Yong P252. Heavy menstrual bleeding, iron deficiency and its impact in exercising females in Singapore
  • cristina benetti-pintp P253. Quality of life in women with deep endometriosis
  • Tatiana Efimenko P254. Features of innervation of ectopic endometrium in women with chronic pelvic pain
  • Patricija Kasilovska P255. Pelvic pain: relation between endometriosis and other factors
  • Olga Leshchenko P256. The frequency of clinical symptoms in a combination of genital tuberculosis and external genital endometriosis in women with infertility
  • Ma. Paula Rhove Ortega P257. Abdominopelvic Tuberculosis Presenting as Vaginal Synechiae with Hematopyotrachelometra
  • Linda Vignozzi P258. Outcome of medical and psychosexual interventions for Vaginismus: a systematic review and meta-analysis
  • Vladimir Zuev P259. The value of express laser spectroscopy in the diagnosis of the uterine abnormalities in perimenopausal women
  • DooSeok Choi P260. Spontaneous pregnancy in patients who received three cycles of gonadotropin-releasing hormone agonist treatment after conservative laparoscopic ovarian endometrioma surgery
  • Fabio Barra P261. Estimation of bowel stenosis degree in women with colorectal endometriosis: a prospective comparative study
  • Gamze Sinem Çağlar P262. Matrix metalloproteinase-9 and neutrophil gelatinase-associated lipocalin levels in advanced stage endometriosis
  • Diana-Elena Comandasu P263. Immunohistochemistry evaluation of endometriosis implants in patients following preoperative progestative treatment
  • Svetlana Dubrovina P264. Prognosis of recurrence of endometrioma after surgery
  • Tatiana Kleimenova P265. Identification of kisspeptins and matrix metalloproteinases in endometrial cell culture from patients with endometriosis
  • Tamara Knific P266. Novel diagnostic models for endometriosis including serum CA-125 levels, body mass index, cyst pathology, dysmenorrhea or dyspareunia
  • Juanqing Li P267. The roles of cell migration and invasion mediated by Twist in endometriosis
  • Ekaterina Pshenichnyuk P268. Immunohistochemical predictive factors for recurrence of ovarian endometrioma after laparoscopic excision
  • Ekaterina Pshenichnyuk P269. Identification of global transcriptome abnormalities in eutopic endometria of women with endometriosis: potential biomarkers of endometriosis
  • Magdalena Rogut P270. Is it possible to diagnose endometriosis at the level of endometrium?
  • cristina benetti-pinto P271. How deep is your love”: evaluation of dyspareunia and sexual function in women with deep infiltrating endometriosis in long-term treatment with dienogest
  • Oleksandra Gromova P272. Low-dose progestins reduse endometriosis associated pain
  • Nigar Kamilova P273. Differentiated approach to the diagnosis and prevention of genital prolapse in women
  • Alexandra Mihaila P274. Can osteopontin be considered a biomarker for endometriosis?
  • Zorana Stojanovic P275. Potential immunoprotective role of dheas on endometriosis in premature ovarian insufficiency patients
  • Maria Yarmolinskaya P276. Investigation of the effects of metformin in a rat endometriosis model.
  • Dzmitry Buryak P277. Pharmacological therapy of uterine fibroids: prediction and durability of treatment effect
  • Maria Yarmolinskaya P278. Changes of molecular characteristics of endometrium in patients with leiomyoma treated with selective progesterone receptor modulators (SPRM)
  • Klaus Nickisch P279. EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human fibroid tissue xenograft model
  • Ekaterina Borovkova P280. The effect of local preparations containing glucocorticoids on indicators of local immunity and the activity of the human papillomavirus Borovkova E. I.
  • Miguel Bedoya Osorio P281. Effect of the administration of 50 mg orally of dehidroepiandrosterone (dhea) during 12 months in: sexual function, somatometry, bone mineral density and metabolic variables of the posmenopausic women of the menopause clinic at the hospital juarez de mexico: preliminary results at 6 months
  • Aleksandar Djogo P282. Influence of the level of dehydroepiandrosterone sulphate (dheas) on the body weight of the climacteric women
  • Joanna Bartosiewicz P283. An analysis of the relationship between the polymorphism of certain genes in candidates for cognitive impairments against cognitive functions in female white-collar workers
  • Gabriella Gyovai P284. Perimenopausal attention deficit as diagnostic challenge
  • Blazej Meczekalski P285. Climacteric symptoms severity and thyroid hormones status in menopausal women.
  • Raquel Picó P286. Using ICT to improve adherence to physical activity with and educational program with postmenopausal women.
  • Eleni Armeni P287. Subclinical atherosclerosis and calcium metabolism in apparently healthy, non-diabetic postmenopausal women.
  • Eleni Armeni P288. Women with the metabolic syndrome have evidence of subclinical arterial disease early after menopause
  • Peter Chedraui P289. Pharmacokinetics of two monthly formulations of non-polymeric microspheres of 17β-estradiol and progesterone administered intramuscularly in an aqueous suspension in postmenopausal women
  • Milton Daniel Flores Fuentes P290. Incidence of insulin resistance in postmenopausal women at Human Reproduction’s Biology clinic during the period 2016 – 2017 at Hospital Juárez de México
  • Evaggelia Karopoulou P291. Subclinical atherosclerosis and lactation history in women after menopause.
  • Yana Kostroma P292. Individual approach to reduction of the risk of somatic pathology in postmenopausal women using hrt
  • Andrea Martínez Massa P293. Cardiovascular risk factors in postmenopausal women from two spanish regions (camargo and carmen cohorts)
  • Denny Salazar-Pousada P294. Weight gain and metabolic changes during the menopausal transition in Ecuadorian women.
  • Guiju Cai P295. Research on Correlation between the Blood Concentration of Progesterone Receptor Membrane Component-1 and the Molecular Subtypes of Breast Cancer Patients
  • Maria Helena Presado P296. Sexuality and Breast Cancer
  • Ying Zhang P297. Can increased expression of progesterone receptor membrane component 1 also indicate a worse prognosis in triple negative breast cancers?
  • Yue Zhao P298. Overexpression of Progesterone Receptor Membrane Component-1 is Associated with Malignant Phenotypes of Breast Cancer
  • Susanna Gasparyan P299. The role of combined hormonal therapy in the correction of cognitive disturbances in women in menopause
  • Nilson Melo P300. Evaluation of risk factors for osteoporosis in post-menopaused women with background of endometriosis and submitted to hormonal treatment.
  • Eliana Nahas P301. Effect of isolated vitamin D supplementation on the bone turnover markers in younger postmenopausal women: randomized, double-blind, placebo controlled trial.
  • Antonina Smetnik P302. Screening for osteoporosis in amenorrheic and postmenopausal women
  • Stefania Alvisi P303. Changes of vulvar and vaginal tissue morphology following ospemifene intake in postmenopausal women with vulvovaginal atrophy (vva)
  • Adriana Carbonel P304. Actions of phytoestrogens or estrogens on the proliferation of the rat in uterine cervix
  • Adriana Carbonel P305. Soybean isoflavone decreases oxidative stress in the uterus and vagina of ovariectomized rats
  • Rodolphe Perard P306. Treating patients with vulvar and vaginal atrophy and a history of breast cancer could substantially reduce the Italian NHS resource use
  • Mekan Orazov P307. Antioxidant – regenerative therapy – a new anti-aging concept of women in peri and postmenopausal age
  • Johann Röhrl P308. Cimicifuga racemosa dry extract (BNO 1055) as active component of Klimadynon® improves sleep quality through GABAA-ergic activity
  • Sofia Thorell P309. Effects of Resistance Training in Postmenopausal Women on Muscle Strength and Total as well as Fat-free Muscle Mass measured with MRI
  • A. Glazunova P310. Low-dose local hormonal therapy for VVA in postmenopausal women.
  • Dubravko Lepusic P311. Education adolescents about sexuall responsible behavior and preventing HPV infections-Health education in Croatia
  • Ziad Abouzeid P312. Expression of vascular endothelial growth factor receptors in endometrial carcinoma
  • Yinmei Dai P313. Identification of DNA hypermethylation of SOX9 in association with cervical cancer using CpG microarrays
  • Kelly Ferreira P314. Non-canonical activation of SHH signaling as a metastatic marker in vulvar cancer
  • Kelly Ferreira P315. Tetraspanins CD63 and CD82 as markers of prognosis in vulvar carcinoma cells
  • Suzana Vidic P316. The importance of estrone-sulfate transporters in endometrial cancer
  • Chenghong Yin P317. Quantitative methylation detection of SOX9 in cervical cancer scrapings using TaqMan probes
  • Anna Drobintseva P318. New approach to detection and analysis of cancer-associated proteins in fluorescent digital microscopy
  • Ziad Abouzeid P319. Potential role of platelets and lymphocytes in epithelial ovarian cancer
  • Natalia Artymuk P320. The predictive value of the self-sampling of human papillomavirus DNA for the diagnosis of HSIL and cervical cancer in different social group
  • Man-Kin Chung P321. The application of community based self-sampling for STD and HPV screenings in Chinese population
  • Maddalena Mallozzi P322. Anamnestic-ultrasound features and endometrial cancer risk in tamoxifen user patients: useful insights in a controversial topic.
  • Nur Nahdiyat P323. Community diagnosis of visual inspection with acetic acid in primary health center of klender district, indonesia
  • Gulaim Ataniyazova P324. Human papilloma virus and cervical pre-cancer
  • Valeria Barra P325. Prevalence of HPV genotipes in the senese female population undergoing cervical screening
  • Russell Ng P326. Neglected HPV infection status in men: A possible underlying cause for persistent high cervical cancer rate among women?
  • Touhami Omar P327. Primary Non-Hodgkin’s Lymphoma of the Ovary – A Case Report
  • ALVARO MONTERROSA-CASTRO P328. Description of the quality of life in colombian women caribbean survivors of breast cancer
  • Omar Touhami P329. A diagnostic dilemma for solid ovarian masses: the clinical and radiological aspects with differential diagnosis of 5 cases
  • Cialuj Teza Agbayani P330. Ovarian masses in children and the trend towards ovarian conservation: a case report
  • Diana-Elena Comandasu P331. Pregnancy outcome after radical vaginal trachelectomy with laparoscopic pelvic lymphadenectomy performed as a fertility preservation technique in patients with early-stage cervical cancer
  • Kristel Danica Panes P332. A Case Of Primary Fallopian Tube Carcinoma Who Underwent Hyperthermic Intraperitoneal Chemotherapy In A Third World Country
  • Ekaterina Borovkova P333. Breast cancer associated with pregnancy. Dobrokhotova J., Danielian S., Borovkova E. аnd Zalesskaya S. A.
  • Lino Del Pup P334. Breast cancer risk of hormonal contraception and hormone replacement therapy: how to counsel and reassure patients considering recent evidence.
  • Maximilian Brincat P335. A Case Of Primary Ovarian Insufficiency In A 21 Year Old Woman With A Strong Family History Of Breast Cancer
  • Alfred Mueck P336. Membrane-initiated effects of Serelys® on proliferation and apoptosis of human breast cancer cells
  • Fulvio Borella P337. Clinicopathological features of pure mucinous breast carcinoma: our experience of 35 cases
  • Muqing Gu P338. Does Norethisterone stimulate human breast cancer cells proliferation by promoting PGRMC1 expression?
  • Aysel Zeynalova P339. Possible benefits of metformin use in patients with breast cancer
  • Nelly Sogoyan P340. Somatic mutations in gene MED 12 among women with the family history of uterine fibroids.
  • Natalia Artymuk P341. The prevalence of the pelvic floor dysfunction of in reproductive age women
  • Balazs Erdodi P342. The Value of Perineal Ultrasound Scan in the Diagnosis of Peri- and Postmenopausal Urinary Incontinence
  • Kiyoko Naito P343. Evaluation of the effectiveness of the motion picture using magnetic resonance images for the pelvic floor muscle training
  • Sanae Ninomiya P344. Effectiveness of the moderately supportive underwear in women with stress urinary incontinence, Part 2: Are the symptoms of urinary incontinence reduced due to wearing the underwear? An assessor-blinded randomized control trial
  • Sanae Ninomiya P345. Effectiveness of the moderately supportive underwear in women with stress urinary incontinence, Part 1: Is the bladder neck elevated due to wearing the underwear?
  • Elisa Malacarne P346. Efficacy and safety of robotic-assisted apical lateral suspension for the treatment of high grade pelvic organ prolapse: short and medium follow up
  • Manuela RUSSU P347. The use of deepithelialized vaginal flap, associated with synthetic mesh fixation at sacrospinous ligaments, for grade 3-4 genital prolapse surgical treatment
  • Manuela RUSSU P348. Sacrosuspension vs fixation at sacrospinous ligaments in pelvic organ prolapse treatment
  • Tommaso Simoncini P349. Single site robotic-assisted apical lateral suspension (ss r-als) for advanced pelvic organ prolapse: first cases reported
  • Rafał Watrowski P350. Laparoscopic, pregnancy-preserving management of massive hemoperitoneum after corpus luteum cyst rupture in early gestation
  • Elena Cecchi P351. Early experience using new integrated table motion for the da Vinci Xi in gynecological surgery: feasibility, safety, efficacy.
  • ahmed galal P352. Accuracy of three –dimensional- ultrasound and Magnetic resonance imaging in the diagnosis of mullerian duct-anomalies
  • SZE MAN LAW P353. Precise Imaging of Endometrium using real time rotational pullback Optical Coherence Tomography: A pilot study
  • Nur Nahdiyat P354. Detection of lactate and other metabolites in ovarian tumours using 1H NMR Spectroscopy
  • Victor Suturin P355. Uterine tissue microcirculation assessment by sidestream darkfiled (SDF) imaging as a complimentary method to ultrasonography: a pilot study.
  • Laura Batres Martínez P356. Ambulatory hysteroscopy: Statistics of our center
  • Laura Batres Martínez P357. Failed ambulatory hysteroscopy: evaluation of patients, causes and treatments
  • Simone Bruni P358. Outpatient Hysteroscopy: factors affecting pain perception
  • Edson Ferreira Filho P359. Hysteroscopic intratubal device Essure® for permanent contraception: clinical outcomes and complications
  • Patimat Khirieva P360. Differential gene expression in the endometrium of reproductive age women with intrauterine adhesions.
  • Elena Nada P361. Hysteroscopy as an Essential Diagnostic Tool in Infertile Women
  • Giulia Nencini P362. Does obesity influence office hysteroscopy? An observational study.
  • Anna Rosner-Tenerowicz P363. Histeroscopic treatment of AUB due to Robert’s Uterus
  • Simona Scarani P364. Correlation between hysteroscopic and anatomopathological finding in endometrial pathology
  • Tanvir Tanvir P365. mbulatory Hysteroscopy for Retained Products of Conception following first trimester medical abortion

Thursday 8th March 2018

08:30 Thursday 8th

Auditorium Meet the Experts 08:30 ￫ 09:30
(DEB01) SPRM

Chairperson/s: Jean Francois Arnal

  • Philipe Bouchard Selective progesterone receptor modulators (SPRMs): update on the clinical results in fibroids
  • Kristina Gemzell Danielsson SPRMs for contraception with added health benefits

Affari 1 Meet the Experts 08:30 ￫ 09:30
(DEB02) Bilateral oophorectomy in pre-menopausal women

Chairperson/s: Martin Birkhaeuser

  • Walter Rocca It is time to stop unjustified oophorectomies
  • John Studd It is time we learn to treat oophorectomized women correctly

Affari 0 Corso Superiore di Ginecologia Endocrinologica AIGE 08:30 ￫ 11:30
(CORSO AIGE01) PCOS e dismetabolismo

Chairperson/s: Alessandro Genazzani

  • Vincenzina Bruni Fattori genetici ed epigenetici predisponenti la PCOS
  • Antonio Cianci L’ insulino resistenza della PCOS e le strategie terapeutiche
  • Antonio Lanzone Il trattamento degli iperandrogenismi
  • Gianluca Gennarelli PCOS e rischio oncologico

Affari 2 Scientific Society Symposium 08:30 ￫ 09:30
Contraception: interesting aspects – Organized by the European Society of Contraception and Reproductive Health (ESC)

Chairperson/s: Gabriele Merki , George Bartfai

  • Regine Sitruk-Ware Potential neurological benefits of progesterone and progestins used in contraception
  • Gabriele Merki Course and treatment of headaches and migraine in the pillfree interval
  • George Bartfai Contraception in women with seizure disorder

Verde Scientific Society Symposium 08:30 ￫ 09:30
Update in Ovarian Cancer- Organized by the Société Européenne de Langue Franco-Allemande de Gynécologie-Obstétrique (SELFAGO)

Chairperson/s: Adolf E. Schindler , René Druckmann

  • Laura Knabben Genetic testing in ovarian cancer
  • Christian Singer Prevention strategies in women with hereditary breast and ovarian cancer syndromes
  • Walther Kuhn Impact of lymph node dissection in ovarien cancer
  • Emmanuel Barranger Advanced ovarien cancer: preoperative prediction of resectibility

Affari 4 Scientific Society Symposium 08:30 ￫ 09:30
The Brazilian experience in Polycystic Ovary Syndrome – Organized by the Sociedade Brasileira de Ginecologia Endocrina (SOBRAGE)

Chairperson/s: Edmund Baracat

  • José Soares-Jr Leraglutide and bariatric surgery. Definituve treatment of PCOS patients
  • Nilson R. De Melo Benefits and harms of combined oral contraceptive in PCOS
  • Sebastiao de Medeiros Clinical and biochemical features of Brazilian PCOS patients

Onice Scientific Society Symposium 08:30 ￫ 09:30
Panel Discussion “From Conception to delivery in Indian PCOS” – Organized by the PCOS Society of India

Chairperson/s: Sujata Kar

  • Sujata Kar .
  • Nalini Mahajan .
  • Anita Soni .
  • Ritu Joshi .
  • Madhuri Patil .

Sala 4 Scientific Society Symposium 08:30 ￫ 09:30
Session organized by the German Society of Gynecological Endocrinology and Reproduction (DGGEF)

Chairperson/s: Ludwig Kiesel , Liselotte Mettler

  • Petra Stute Measuring active and healthy ageing
  • Martin Goette MicroRNAs – ready for endometriosis diagnostics ?
  • Annette Bachmann PCOS – a lifelong disorder ?
  • Amanda Machado Weber Metformin and endometrial function

09:45 Thursday 8th

Auditorium Symposium 09:45 ￫ 11:15
(Symp07) Premature labor: how to prevent, how to manage

Chairperson/s: Peter Chedraui , Takeshi Maruo

  • Tomoyuki Fujii Omega-3 polyunsaturated fatty acid and preterm birth
  • Fabio Facchinetti Maintenance tocolysis. Still unsolved problem
  • Gian Carlo Di Renzo Prediction and prevention of preterm birth
  • Christian Egarter Progesterone: mode of action in preterm labor

Affari 1 Scientific Society Symposium 09:45 ￫ 11:15
Alliance of the surgeon and gynecologist-endocrinologist in reproductive medicine – Organized by the Russian Association of Endometriosis

Chairperson/s: Leila Adamyan , Vladimir N. Serov

  • Leila Adamyan Endometriosis – an integrated approach of the treatment
  • Maria Yarmolinskaya Infertility in patients with gynecological diseases – the role of hormone therapy in the preparation for IVF and in the luteal phase support
  • Irena Kozachenko Optimization of infertility treatment results in gynecological patients. Role of the surgeon in the preparation for IVF. “Pros and cons”
  • Nana Tetruashvili Recurrent pregnancy loss
  • Martynov Sergei and Arakelyan Alek Postoperative synechiae, inconsistent uterine scar and niches. Methods of diagnosis, surgical and medical treatment

Affari 2 Symposium 09:45 ￫ 11:15
(Symp12) ART – New therapies and new challenges: the individual factors

Chairperson/s: Paolo Artini , Zion Ben Rafael

  • Jacques Cohen Assisted reproductive technology treatments, limitations and prospects for mitochondrial disease carriers
  • Basil Tarlatzis The use of androgens or androgen – modulating agents in poor responders undergoing in vitro fertilization
  • Alberto Revelli Multivariate prediction model for IVF results: a tool to get benchmark

Verde Scientific Society Symposium 09:45 ￫ 11:15
Menopause medicine: think sexuality! – Organized by the International Menopause Society (IMS)

Chairperson/s: Mary Ann Lumsden , Sunila Khandelwal

  • Susan Davis Sexuality and the postmenopausal woman
  • Rossella E. Nappi Treating sexual symptoms at midlife
  • Michael van Trotsenburg Sexuality of Transgender Persons
  • Susan Davis New process of care for HSDD

Affari 4 Scientific Society Symposium 09:45 ￫ 11:15
Gynecological Endocrinology and the Women Health’s future – Organized by the Asociacion Latinoamericana de Endocrinología Ginecologica (ALEG)

Chairperson/s: Alejandro Paradas Caba , Alejandro Manzur

  • German Salazar Trends in contraceptives use among adolescents
  • Imelda Hernandez Long term polycystic ovarian syndrome complications
  • Selva Lima Obesity its gynecological endocrine repercussion
  • Cuauhtemoc Celis-Gonzalez MHT: risks and benefits
  • Gerardo Broutin Conclusions
  • Lidia Sosa Conclusions

Onice Oral Presentation 09:45 ￫ 11:15
(OP01) Amenorrhea and stress related hypothalamic disorders

Chairperson/s: Metella Dei , Laura Gaspari

  • Fabio Cesar Prosdocimi Effects of sex steroids on serum prolactin concentration in mice with metoclopramide-induced hyperprolactinemia
  • Antonio Mancini Oxidative stress as a link between hormonal picture and bone turnover in hypothalamic amenorrhea
  • Francesca Parissone Fertility preservation in a young woman with Turner-like phenotype due to chromosomic aberration
  • Anna Loktionova Diagnostic value LH and FSH levels in female patients with central hypogonadism
  • Aikaterini Giannouli Two interesting cases of primary amenorrhea with double pathology
  • Diletta Mauro Effects of estroprogestin therapy on premenstrual exacerbation of meniere’s disease
  • Anna Dittfeld The Use of Steroids by Gym Athletes: an Attempt to Diagnose the Problem Scale and Possible Causes
  • Aikaterini Giannouli Metabolic burden in adolescents with secondary Functional Hypothalamic Amenorrhea: is the risk real?
  • Vasileios Karountzos Total body fat mass combined with its distribution to trunk can predict menstrual recovery and positively influence the psychopathology of adolescents with Anorexia Nervosa
  • Dmitry Gusev A new index for the differential diagnosis of various forms of functional hypothalamic amenorrhea

Sala 4 Oral Presentation 09:45 ￫ 11:15
(OP02) Endocrine disorders and other pathologies: impact on reproductive function

Chairperson/s: Mario Maggi , Antonio S. Laganà

  • Anna Kostrzak Bone mineral density in women with hyperprolactinaemia.
  • PINAR BAHAT Effects of neural therapy in patients with abnormal (dysfunctional) uterine bleeding
  • Faina Guseinova The characteristics of disorders of reproductive function in women with genital tuberculosis
  • Mónica Flores-Ramos Testosterone levels comparison between bipolar and depressed women.
  • Pedro Antonio Regidor Identification and prediction of the fertile window with a new web-based medical device using a vaginal biosensor for measuring the circadian and circamensual core body temperature
  • Sarah Johnson Failure to predict ovulation by Apps when applied to menstrual cycles of women trying to conceive
  • Svetlana Vorotnikova Features of pituitary-ovarian axis functioning in woman of reproductive age with acromegaly and Cushing’s disease.
  • Dimitrios Anastasios Bountouvas Spontaneous Conception After Hyperprolactinemia Treatment In Laron Syndrome Patient
  • Leonor Burgos Martínez Differences in gonadal hormone levels in women with treatment resistant depression and treatment responsive depression
  • Anna Dittfeld Epstein-Barr virus infection in patients with autoimmune thyroid disease
  • Ricardo Simoes Analysis of oxidative stress and apoptosis in the ovary of rats treated with soybean isoflavones
  • Anastasia Kudrytskaya Menstrual function and Endocrine Status in Kidney Transplanted Women

11:15 Thursday 8th

Break

11:45 Thursday 8th

Auditorium Symposium 11:45 ￫ 13:15
(Symp26) Estetrol and Breast Cancer

Chairperson/s: Nicoletta Biglia , Herjan Coelingh Bennink

  • Richard J. Santen Estetrol in animal in vivo studies
  • Risto Erkkola Estetrol in ex vivo explant cultures of human breast cancer tissue
  • Herjan Coelingh Bennink Estetrol treatment of advanced breast cancer

Affari 1 Symposium 11:45 ￫ 13:15
(Symp23) Urogenital aging

Chairperson/s: Farook Al-Azzawi , Pierluigi Benedetti Panici

  • Nick Panay Impact and management of VVA / GSM – an evidence based approach
  • Tomi Mikkola Stress urinary incontinence risk in women using HRT
  • Camil Castelo Branco VVA in young women
  • Tommaso Simoncini Managing pelvic organ prolapse between hormones and surgery

Affari 2 Symposium 11:45 ￫ 13:15
(Symp29) Reproductive impairment: from nature to therapies

Chairperson/s: Jonathan Ramsay , Moncef BenKhalifa

  • Alessandro D. Genazzani Stress and hypothalamic amenorrhea
  • Rossella E. Nappi New therapies for Impairment of female sexual desire
  • Gian Maria Busetto Male reproductive failure: how to face

Verde Symposium 11:45 ￫ 13:15
(Symp18) Cardiovascular protection and life long risk factors: diagnosis and management

Chairperson/s: Sven Skouby

  • Irene Lambrinoudaki Obstetrical history and cardiovascular risk in later life
  • Sven Skouby HT: pharmacology tailored to women’s health
  • Antonio Cano Symptoms and hormones: fine-tuning atherosclerotic risk ?
  • Peter Collins Cardiovascular risk management in women – an update, what’s new ?

Affari 4 Scientific Society Symposium 11:45 ￫ 13:15
Obesidad y su impacto en la salud reproductiva de la mujer – Organized by the Federacion Latina de Endocrinología Ginecologica (FLEG)

Chairperson/s: Nestor Siseles , Rafael Camacho

  • Greta Solis Epidemiology of overweight in Latin American women
  • Manuel Noelting Obesity: its impact on the menstrual cycle
  • Gustavo Gomez SOA, obesity and insulin resistance
  • Pablo Lavin Obesidad en mujeres en edad del climaterio
  • Gustavo A. Maciel Low grade chronic inflammation in brasilian obese PCOS
  • Javier Saavedra Trigliceridos y HDL. Importancia en DX y tratamiento de dislipidemias

Onice Oral Presentation 11:45 ￫ 13:15
(OP03) Pregnancy: abortion and recurrent pregnancy loss

Chairperson/s: Gian Carlo Di Renzo , Bruno Mozzanega

  • Gaurav Desai Second Trimester Medical Termination of Pregnancy with Combined Intracervical and Intravaginal Misoprostol: Comparative Analysis with Intravaginal Misoprostol-A Pilot Study.
  • Agnieszka Dubiel The prevalence of MTHFR gene mutation in AITD women with history of miscarriage
  • Irina Zhukova Pro- and antiapoptotic proteins BCL-2 and Bax in endometrium of patients with miscarriages.
  • Alana Agnaeva Role of NK cells in early reproductive losses
  • Natasha Kashyap Role of altered Notch signalling in the pathogenesis of recurrent pregnancy loss (RPL): A northeast Indian cohort based pilot study
  • Margarita Bakleicheva The role of vitamin D for threatened miscarriage in the first trimester of pregnancy
  • Irina Zhukova Intracellular pattern-recognition receptors, recognizing viruses, in pathogenesis of missed and spontaneous abortions.
  • Elena Khazova Two seasons of the level of calcidiol in pregnant women of St. Petersburg.
  • Anjuma Begum Role of low vitamin d3 levels and linked deregulated placental apoptosis in recurrent pregnancy loss (RPL) pathogenesis: a study from northeast India
  • Amélie Keller Concentration of vitamin d from neonatal dried blood spots and the relation to gestational age, birthweight and ponderal index: the d-tect study

Sala 4 Oral Presentation 11:45 ￫ 13:15
(OP04) Assisted Reproduction Technologies: from induction of ovulation to endometrial receptivity therapies

Chairperson/s: Jacques Cohen , Alberto Revelli

  • Maria Costanza Chiti A tailored protocol for human ovarian follicle isolation for clinical application
  • samir Elsayed Higher Body Mass Index Significantly Affects Intracytoplasmic Sperm Injection Success Rate
  • Leila Nazari Effects of autologous platelet-rich plasma in repeated implantation failure: a randomized controlled trial
  • AISHA ELBAREG Efficacy of Letrozole (LE) Combined with Cabergoline (CE) in Comparison to LE alone in ovulation induction among patients with Polycystic Ovarian Syndrome (PCOS) and Hyperprolactinemia (HP): Our Experience
  • Natalia Pasman Regulatory T cells in the ovarian follicular fluid of infertile women
  • Vladimir Zuev REGENERATION OF ATROPHIC ENDOMETRIUM IN ART PROGRAMS. EFFECT OF PHOTOTHERAPY. LONG-TERM RESULTS.
  • Anastasia Beta Clomiphene Citrate in addition to gonadotropins may improve ovarian response in poor responders
  • Miguel Estrada Supplementation of exogenous LH in patients with poor ovarian response in controlled ovarian stimulation.
  • Mirela Iancu Does vitamin D influence the in vitro fertilization outcome?
  • Livia Munhoz Does high progesterone levels on ovarian stimulation cycles damage the quality oocytes collected?
  • Loris Marin The impact of thyroid autoimmunity on embryo quality in women undergoing assisted reproductive technology.
  • Lu Wang DAF promotes endometrial cells proliferation and motility under ovarian hormone stimulation
  • Oxana Melkozerova Tissue and molecular effects of the cavitated solution in the endometrial receptivity rehabilitation of patients with the uterine infertility

12:00 Thursday 8th

Affari 0 Sponsored Key Lecture 12:00 ￫ 12:30

    12:45 Thursday 8th

    Affari 0 Sponsored Key Lecture 12:45 ￫ 13:15

      13:30 Thursday 8th

      Affari 1 Sponsored Lunch Symposium 13:30 ￫ 15:15

        Affari 0 Sponsored Lunch Symposium 13:30 ￫ 15:15

          15:15 Thursday 8th

          Break

          15:45 Thursday 8th

          Auditorium Meet the Experts 15:45 ￫ 16:45
          (DEB09) Should we re-think the role of gonadotrophins after the menopause?

          Chairperson/s: Philippe Bouchard

          • Tommaso Simoncini Gonadotrophins and breast cancer
          • Xiaodong Fu Gonadotrophins and cardiovascular disease

          Affari 1 Sponsored Meet the Experts 15:45 ￫ 16:45

            Affari 0 Meet the Experts 15:45 ￫ 16:45
            (DEB05) Stress and reproduction

            Chairperson/s: Anna Maria Paoletti

            • Sarah Berga Does stress causes infertility?
            • Alessandro D. Genazzani Integrative treatment to overcome the neuroendocrine impairment

            Affari 2 Sponsored Meet the Experts 15:45 ￫ 16:45

              Verde Sponsored Meet the Experts 15:45 ￫ 16:45

                Affari 4 Meet the Experts 15:45 ￫ 16:45
                (DEB08) Ovarian tumors

                Chairperson/s: Javier Domingo

                • Manuel Nölting Androgen secreting tumors
                • Pierluigi Benedetti Panici Update on cytoreductive surger for advanced ovarian cancer

                Onice Oral Presentation 15:45 ￫ 16:45
                (OP05) Endometrial Hyperplasia and Endometrial Cancer

                Chairperson/s: Massimiliano Fambrini , Attilio Di Spiezio Sardo

                • Chunlin Su Effect and evaluation of hysteroscopy on Fertility-preserving Treatment of endometrial atypical hyperplasia and early endometrial adenocarcinoma in PCOS patients ：a retrospective study
                • Xing Wei Effect of electric field on endometrial adenocarcinoma cell and NO secretion
                • Cristina Benetti-Pinto The use of tamoxifen as a malignancy risk in women with endometrial polyp
                • Tamara Knific Sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer
                • Madina Dumanovskaya Atypical endometrial hyperplasia is always equivalent refers to endometrial intraepithelial neoplasia, whereas it is not always endometrial intraepithelial neoplasia refers to atypical endometrial hyperplasia
                • Mariami Andguladze Endometrial Hyperplasia – New Vector of Treatment
                • Huixiao Wang Effects of 17β-estradiol on endometrial cancer cell proliferation and HOTAIR expression
                • Chunlin Su Reverse of Endometrial Atypical Hyperplasia and Early endometrial carcinoma in PCOS women by Dydrogesterone plus Metformin:a pilot study
                • Gonda Konings Blocking 17β hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach

                Sala 4 Oral Presentation 15:45 ￫ 16:45
                (OP06) Gynecological Surgery

                Chairperson/s: Liselotte Mettler , Marie-Madeleine Dolmans

                • Gaurav Desai Robotically assisted hysterectomy for staging endometrial cancer: Experience at a tertiary care institution in India
                • Gianluca Damiani Comparison of the perioperative outcomes of vessel sealing instrument –assisted technique hysterectomy with conventional hysterectomy
                • Anna Rosner-Tenerowicz The assessment CO2 laser treatment of vulvovaginal atrophy and its influence on urine incontinence
                • Mariana Rebeca Garcia Elias Laparoscopic neovagina creation by davydov’s procedure: evaluation of the vaginal function and sexual satisfaction with follow-up to one year.
                • Bakhodir Kurbanov Improved surgical technique to treatment of genital prolapse.
                • Salvatore Giovanni Vitale Transvaginal bilateral sacrospinous fixation after second recurrence of vaginal vault prolapse: anatomical and functional outcomes, quality of life and sexual function.

                16:45 Thursday 8th

                Auditorium Symposium 16:45 ￫ 18:15
                (Symp21) Premature Ovarian Insufficency

                Chairperson/s: Camil Castelo-Branco , Walter Rocca

                • Farook Al-Azzawi Determinants of oocytes reserve and depletion
                • Nick Panay POI: progress through a global registry
                • Bart CJM Fauser POI: implications for cardiovascular health
                • Svetlana Vujovic Hypoestrogenism and insulin resistance in premature ovarian insufficiency: is it time dependent?

                Affari 1 Symposium 16:45 ￫ 18:15
                (SYMP27) Fertility preservation: possibilities and strategies

                Chairperson/s: Christian Egarter , Antonio Lanzone

                • Zion Ben Rafael The dilemma of social freezing
                • Marie-Madeleine Dolmans Ovarian tissue cryopreservation and transplantation: which success for 2018 ?
                • Javier Domingo Oocyte cryopreservation or tissue transplantation for fertility preservation in cancer patients: what is best ?

                Affari 0 Symposium 16:45 ￫ 18:15
                The role of exogenous sex hormones in pregnancy (Organized by the PREIS School Academy session)

                Chairperson/s: Gian Carlo Di Renzo , Peter Platteau

                • Peter Platteau Role of exogenous sex hormones in medically assisted pregnancy
                • Mary Stephenson Role of sex hormones in recurrent pregnancy loss
                • Paul Piette The basics of progestogens and estrogens
                • Gian Carlo Di Renzo Role of exogenous sex hormones in perinatal period and on the preterm new born

                Affari 2 Sponsored Symposium 16:45 ￫ 18:15

                  Verde Symposium 16:45 ￫ 18:15
                  (Symp16) Menopausal transition

                  Chairperson/s: Antonio Cano , Susan Davis

                  • Tommaso Simoncini Neuroendocrine changes of the menopausal transition
                  • Pauline Maki Cognition and hot flashes: a scientific update
                  • Mary Ann Lumsden Following Guidelines – what should we say to those with heart disease ?
                  • Santiago Palacios Effects and management of the menopausal transition on vulvo-vaginal tissue

                  Affari 4 Oral Presentation 16:45 ￫ 18:15
                  (OP07) Polycystic Ovary Syndrome

                  Chairperson/s: Manuel Noelting , Andrea Giannini

                  • Shahnoza Kalanhodjaeva Comparative analysis of clinical and hormonal parameters in women with hyperandrogenemia adrenal and ovarian genesis
                  • Geranne Jiskoot Effects on body weight of a 1-year three-component lifestyle RCT in obese PCOS women.
                  • Gokce Anik Ilhan Cardiotrophin-1 as a new metabolic biomarker in women with PCOS.
                  • Elene Asanidze Anti-Mullerian Hormone is a Useful Marker for the Assessment of the Treatment Efficiency in Patients with Polycystic Ovary Syndrome (PCOS)
                  • Adam Czyzyk Evolving endocrine and metabolic milieu of PCOS with aging
                  • Mariana Paulson Endometrial expression of anti-müllerian hormone and its receptor in obese women with PCOS- a lifestyle intervention study
                  • Szilvia Csehely Laboratory and etiology characteristics of PCOS phenotypes
                  • Rhea Jabbour Assessment of carotid intima-media thickness in patients with polycystic ovary syndrome and its association with hormonal and lipid profiles
                  • Chiara Sabbadin Vitamin D deficiency in polycystic ovary syndrome
                  • Aleksandra Atanasova Boshku Lipid Accumulation Product (LAP), Waist to Hip Ratio (WHR) and Waist Circumference to Height Ratio (WGtR) associated with hormonal profile in women with Polycystic ovary syndrome
                  • Aleksandra Atanasova Boshku Hyperandrogenemia and lipid profile in women with polycystic ovary syndrome
                  • Hilma Lubis Fibrinolytic Activity in Woman with Polycystic Ovary Syndrome (PCOS)
                  • Swati Sharma evaluation of effect of vitamin D supplementation on serum AMH in vitamin D deficient PCOS women

                  Onice Oral Presentation 16:45 ￫ 18:15
                  (OP08) Endometriosis: ethiology and pathogenesis

                  Chairperson/s: Giuseppe Morgante , Silvia Vannuccini

                  • Tianjiao Pei miR-194-3p represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis
                  • Manijeh Mehdinejad Endometriosis and adenomyosis in adolescents, fertile and menopausal women
                  • Lutz Konrad Endometrium and Endometriosis – It is all the same from a cellular perspective
                  • Antonella Biscione DHEA and DHEA-S concentrations in plasma and saliva samples of women affected by endometriosis
                  • Yana Aznaurova Transcriptomic data of eutopic endometrium as a basis for a minimally invasive test of endometriosis.
                  • Maša Sinreih AKR1C3 levels in ovarian, peritoneal and deep infiltrating endometriosis
                  • Javier García Solares The concept of invasion in deep nodular endometriosis.
                  • Li Xiao miR22-5p targets TET2 and regulates the Estrogen receptor 2 expression in infertile women with mild or minimal endometriosis during implantation window

                  Sala 4 Oral Presentation 16:45 ￫ 18:15
                  (OP09) Breast Cancer

                  Chairperson/s: Risto Erkkola , Christian Singer

                  • Christel Pequeux Dose-dependent effect of estetrol (E4) on mammary gland and breast cancer: an opportunity for new menopause treatments
                  • Ambrogio P Londero Breast cancer development in patients with borderline breast lesions
                  • Marina Willibald Progesterone Receptor Membrane Component-1 is Phosphorylated upon Progestin Stimulation and Binds to Estrogen Receptor α-Coregulators PHB1 and PHB2 in Breast Cancer Cells
                  • Marina Willibald PGRMC1 Promotes Tumour Progression of Breast Cancer through Upregulation of ERα Expression and EGFR signalling
                  • Anna Rasmussen Adult granulosa cell tumor associated with breast cancer in Denmark 1964-2016
                  • Foteini Anifantaki Hormone receptor expression in pregnancy- associated breast cancer: a systematic review of the literature
                  • Vanessa Trindade Evaluation of ovarian function in young women after breast cancer chemotherapy treatment
                  • Xiaosa Li GPER1 Promotes Estrogen Receptor Negative Breast Cancer Cells Migration and Invasion via Nongenomic Activation of c-Src/NF-κB/Focal Adhesion Kinase Cascade

                  18:15 Thursday 8th

                  Auditorium ISGE General Assembly 18:15 ￫ 19:30
                  ISGE General Assembly

                  Affari 1 Scholarship Course 18:15 ￫ 19:30
                  Scholarship Course

                  • Howard Carp Obstetric Endocrinology
                  • Richard J. Santen Hormones and Cancers

                  Friday 9th March 2018

                  08:30 Friday 9th

                  Auditorium Meet the Experts 08:30 ￫ 09:30
                  (Deb07) Progesterone and SPRMs effects on endometrium for decidualization and receptivity

                  Chairperson/s: Anna Glasier

                  • Fernando Reis Progesterone-induced paracrine factors in human endometrium: the key for decidualization and receptivity
                  • Bruno Mozzanega Ulipristal and the human endometrium: : the case of Emergency contraception

                  Affari 1 Meet the Experts 08:30 ￫ 09:30
                  (DEB04) The vaginal and endometrial microbiota

                  Chairperson/s: Svetlana Vujovic

                  • Gary Ventolini Intravaginal and endometrial microbiota are important for human reproduction
                  • Inmaculada Moreno Study of the endometrial microbiota to improve ART outcomes

                  Affari 0 Corso Superiore di Ginecologia Endocrinologica AIGE 08:30 ￫ 11:30
                  (CORSO AIGE02) Management della Terapia Ormonale Sostitutiva

                  Chairperson/s: Carmine Nappi

                  • Rossella E. Nappi Sintomi climaterici come marker di vulnerabilità biologica
                  • Anna Maria Paoletti Quando integrazione e quando sostituzione ormonale
                  • Vincenzo De Leo PCOS e menopausa: nuove opzioni terapeutiche
                  • Angelo Cagnacci L’evoluzione della TOS: combinata ciclica o continua, steroidi di sintesi o TSEC

                  Affari 2 Scientific Society Symposium 08:30 ￫ 09:30
                  Gynecological surgery: from complications to new possibilities – Organized by the International Academy of Human Reproduction (IAHR)

                  Chairperson/s: Leila Adamyan , John Sciarra

                  • Liselotte Mettler Fibroids and malignancy potentials in reproductive surgery
                  • Joseph Schenker Complications of ART technology
                  • Andrea Giannini, Tommaso Simoncini Horizons in gynecologic robotic surgery

                  Verde Scientific Society Symposium 08:30 ￫ 09:30
                  Hot topics in Gynecological Endocrinology – Organized by the Polish Society of Gynecological Endocrinology

                  Chairperson/s: Blazej Meczekalski , Andrzej Milewicz

                  • Grzegorz Breborowicz Obesity – what kind of problem it is in contemporary perinatology?
                  • Agnieszka Podfigurna Hyperandrogenism related to androgen secreting ovarian tumors
                  • Krzysztof Lukaszuk Endometrial receptivity and luteal phase support
                  • Blazej Meczekalski Fertility in women of late reproductive age

                  Affari 4 Scientific Society Symposium 08:30 ￫ 09:30
                  Aspects related to middle-aged women – Organized by the Asociacion Argentina para el estudio del Climaterio (AAPEC)

                  Chairperson/s: Rita Caro , Elida Rodriguez

                  • Claudia Rey Osteopenia: when and how to intervene?
                  • Monica Nanez Are local hormones really important in genitourinary urinary tract?
                  • maria belardo Sleep disorders in perimenopausal women, and metabolic syndrome
                  • Blanca Campostrini Treatments for menopausal symptoms: which are the best options.?
                  • Cristina Montero Discussion

                  Onice Scientific Society Symposium 08:30 ￫ 09:30
                  Male Contraception under the auspices of ICMC – Organized by the International Consortium for Male Contraception (ICMC)

                  Chairperson/s: David Serfaty , Regine Sitruk-Ware

                  • David Serfaty Activities and update of ICMC
                  • Cristina Meriggiola Overview on male hormonal contraception
                  • Regine Sitruk-Ware Possible non contraceptive benefits of hormonal male contraception
                  • Mario Festin WHO efficacy study on male contaception: last update

                  Sala 4 Oral Presentation 08:30 ￫ 09:30
                  (OP10) Gynecological Cancers

                  Chairperson/s: Massimo Stomati , Franco Borruto

                  • Giorgio Bogani Potential Implication on the Introduction of the Nonavalent Vaccination Against HPV: an analysis HPV prevalence in 13,665 patients over a 18-year study period
                  • Maria Luisa Gasparri Immune response to Chemotherapy-Associated Antigens as preoperative predictor of oncologic outcome in Ovarian Cancer patients: a pilot study
                  • Hexia Xia Follicle loss and PTEN/PI3K/mTOR signaling pathway activated in LepRb-mutated mice
                  • Alexandra Asaturova Innovative liquid-based cytology of fallopian tube smears in intraepithelial precancerous lesions diagnostics
                  • Anna Protasova Safety of prescribing MGT after successful treatment of CIN and squamous cell carcinoma of the cervix.
                  • Bruna De Almeida Expression of miR-148a, miR-152 and miR-21 and genetic interactions network in uterine leiomyosarcoma cells
                  • Giorgio Bogani Introducing Nerve-Sparing Approach during Minimally Invasive Radical Hysterectomy for Locally-Advanced Cervical Cancer: A multi-Institutional Experience

                  09:45 Friday 9th

                  Auditorium Symposium 09:45 ￫ 11:15
                  (Symp14) Neurosteroids as regenerative agents

                  Chairperson/s: Cordian Beyer , Luis M. Garcia-Segura

                  • Roberta Brinton Diaz Allopregnanolone as a therapeutic to regenerate the degenerating brain
                  • Michael Schumacher Progesterone and stroke
                  • Regine Sitruk-Ware Effects of progesterone and nestorone on myelin

                  Affari 1 Scientific Society Symposium 09:45 ￫ 11:15
                  Alternative treatment methods of patients with benign tumors and hyperplastic processes of the uterus in women of reproductive age- Organized by the Russian Society of Reproductive Medicine and Surgery

                  Chairperson/s: Leila Adamyan , Vladimir N. Serov

                  • Leila Adamyan Management of patients with uterine fibroids from the age perspective
                  • Vitaly Bezhenar Combined hyperplastic processes of the organs of reproductive system in women with infertility
                  • Victoria Kasyan Medical aspects of contraception
                  • Galina Chernukha PCOS and infertility
                  • Elena Andreeva Role of the gynecologist in the detection of benign breast tumors from the perspective of cancer prevention

                  Affari 2 Sponsored Symposium 09:45 ￫ 11:15

                    Verde Symposium 09:45 ￫ 11:15
                    (Symp03) PCO: genetic, epigenetic and metabolic risk factors

                    Chairperson/s: Xiangyan Ruan , Basil Tarlatzis

                    • Jerome Strauss Genetic and epigenetic factors contributing to the hyperandrogenemia of PCOS
                    • Charles Sultan Adolescent PCOS: an entity?
                    • Alessandro D. Genazzani Metabolic impairment and new therapeutic strategies for PCOS
                    • Andrzej Milewicz Serum bisphenol A and metabolic profile in women with PCOS
                    • Archil Khomasuridze PCOS: the new approach

                    Affari 4 Scientific Society Symposium 09:45 ￫ 11:15
                    Clinical challenges in the menopause transition – Organized by the Latino-American Federation of Climateric and Menopause Societies (FLASCYM)

                    Chairperson/s: Sonia Cerdas , Zully Benitez

                    • Sonia Cerdas The endocrinology of menopause transition
                    • Nestor Siseles Risks and indications of contraception
                    • Alejandro Paradas Achieving pregnancies during MT
                    • Maria Teresa Espinoza Hot flashes and migraines approach
                    • Silvina Witis Management of abnormal bleeding
                    • Cuauhtemoc Celis-Gonzalez Bone health during MT
                    • Alejandra Elizalde Cremonte Questions and closing remarks
                    • Greta Solis Questions and closing remarks
                    • Maria Alejandra Schuele Questions and closing remarks

                    Onice Scientific Society Symposium 09:45 ￫ 11:15
                    Role of progestogens in women’s health: an up-date – Organized by the European Progestogen Club (EPC)

                    Chairperson/s: Adolf E. Schindler , René Druckmann

                    • Pedro-Antonio Regidor Role of progestogens in women’s health: an update. Clinical relevance in present day hormonal contraception
                    • Alfred Mueck Choice of progestogen for HRT in menopausal women
                    • Sven Skouby Impact of progestogenes on hemostasis
                    • Nicola Pluchino Brain progesterone metabolite: Allopregnanolone production and its regulation
                    • Vitaly Tskhay Results of hormone therapy and recovery of the patients with severe forms of adenomyosis

                    Sala 4 Oral Presentation 09:45 ￫ 11:15
                    (OP13) Menopause: vascular effects and cardiovascular diseases

                    Chairperson/s: Damir Franic , Margaret Rees

                    • Alfred Mueck Vasodilative potency induced with Estradiol in women with and without CAD during standardized stress:- two parallized, randomized, double-blind, placebo-controlled cross-over studies
                    • Anna Dalla Cà Acute effect of estrogens stimulation -triptorelin induced on heart ECG parameters in patients with polycystic ovary syndrome
                    • Tord Naessen Improved inflammation markers during menopausal hormone therapy correlate to ultrasonographic signs of vascular benefit. – a randomized-controlled study
                    • Yizhou Huang Function and mechanism of estrogen in regulating vascular endothelial barrier
                    • Anne Gallez Inclusion of 17β-estradiol into liposome: a new tool to study the molecular mechanisms of estrogen receptors
                    • Mahsa Noroozzadeh The effect of prenatal exposure to a single dose of testosterone on cardiac function of male and female rats in adulthood
                    • Cindy Meun High androgen levels in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study
                    • Ping Li 17b-Estradiol Enhances Vascular Endothelial Ets-1/ miR-126-3p Expression: The Possible Mechanism for Attenuation of Atherosclerosis
                    • Eleni Armeni The TYG index as a potential predictor of subclinical vascular disease after the menopause
                    • Hai Jiang Changes in cardiovascular function based on adrenalin and norepinephrine metabolism in ovariectomized rats
                    • Hai Jiang Proteomics in plasma of ovariectomized rats and those exposed to estradiol valerate

                    11:15 Friday 9th

                    Break

                    11:45 Friday 9th

                    Auditorium Symposium 11:45 ￫ 13:15
                    (Symp15) Neuroprotection

                    Chairperson/s: Roberta Brinton , Michael Schumacher

                    • Luis Garcia-Segura Neuroprotective action of estradiol and estrogen receptors
                    • Walter Rocca Sex, gender, and the decline of dementia
                    • Andrea R. Genazzani Adrenal androgens impact on neurosteroids
                    • Cordian Beyer Estradiol control of brain inflammation and pyroptosis

                    Affari 1 Symposium 11:45 ￫ 13:15
                    (Symp02) Androgens

                    Chairperson/s: Duru Shah , Jerome Strauss, III

                    • Charles Sultan Management of adolescent hyperandrogenism: still a challenge !
                    • Angelica Hirschberg The role of androgens for body composition and physical performance in women
                    • Susan Davis Testosterone and cardiovascular health after menopause, a benefit or risk?
                    • Zana Bumbuliene Hyperandrogenism in adolescents

                    Affari 2 Symposium 11:45 ￫ 13:15
                    (Symp20) Osteoporosis: a long life risk for women

                    Chairperson/s: Mark Brincat , Faustino Perez-Lopez

                    • Martin Birkhaeuser Prevention of osteoporosis in anorexia nervosa: what is new?
                    • John Stevenson HRT for prevention of osteoporosis
                    • Tobias De Villiers New drug development in osteoporosis

                    Verde Symposium 11:45 ￫ 13:15
                    (Symp10) Endometriosis/Adenomyosis: from basic science to clinics

                    Chairperson/s: Leila Adamyan , Luigi Devoto

                    • Caterina Exacoustos The role of transvaginal U/S in the diagnosis of endometriosis and adenomyosis
                    • Ludwig Kiesel Regulation of proliferation and invasion in endometriosis
                    • Robert Taylor Cell biology of nascent endometriosis implants
                    • Nicola Pluchino Role of bone marrow-derived cells in endometriosis development

                    Affari 4 Scientific Society Symposium 11:45 ￫ 13:15
                    Management of healthy ageing – Organized by the European Menopause and Andropause Society (EMAS)

                    Chairperson/s: Tommaso Simoncini , Irene Lambrinoudaki

                    • Michael van Trotsenburg Aging in Transgender Men and Women
                    • Margaret Rees Diet and lifestyle interventions for midlife health and beyond
                    • Alfred Mueck Impact of menopausal hormone therapy on morbidity and mortality
                    • Antonio Cano () Concept of healthy ageing according to EIP on AHA

                    Onice Oral Presentation 11:45 ￫ 13:15
                    (OP12) Assisted Reproduction Technologies: predictive markers, OHSS and ethical aspects

                    Chairperson/s: Inmaculada Moreno , Elisabetta Coccia

                    • Giulia Murru Plasmatic androgens as predictors of ovarian response in ART: a prospective cohort study.
                    • Antonio Mancini Infertility as an indication for provocative testing of Growth Hormone
                    • Svetlana Zhukovskaya Prognostic markers of ovarian hyperstimulation syndrome in assisted reproductive technologies
                    • Amerigo Vitagliano Endometrial scratch injury before intrauterine insemination: Is it time to re-evaluate its value? Evidence from a systematic review and meta-analysis of randomized controlled trials.
                    • Piyush Bansal The role of GnRH analogues(GnRH-a) in improving outcome in women undergoing super-ovulation (SO) and intra-uterine insemination (IUI) after surgical correction of minimal to mild endometriosis: a randomized control trial.
                    • Diana Mihai What to do with the surplus cryopreserved embryos? The view in accordance with the principles of bioethics
                    • Parnaz Borjian Boroujeni Thrombophilic genes alterations as risk factor for OHSS
                    • Tiffanny Jones Lavender aromatherapy to reduce anxiety during intrauterine inseminations: a randomized, controlled trial
                    • Taisiia Yurchuk Multiple pregnancy rate and single transfer of either fresh or cryopreserved embryo.

                    Sala 4 Oral Presentation 11:45 ￫ 13:15
                    (OP11) Pre-Eclampsia and Pregnancy Induced Hypertension

                    Chairperson/s: Fernando Reis , Filiberto Severi

                    • Tetiana Loskutova New approaches to the prognosis of preeclampsia in pregnant woman
                    • Dorota Darmochwal-Kolarz The role of Placental Growth Factor and Endoglin in the pathogenesis of pre-eclampsia
                    • Lucia Maria Procopciuc Newborn genotypes associated with endothelial dysfunction as a risk factor for mild and severe preeclampsia
                    • Svetlana Dubrovina Early predictors of late-onset preeclampsia
                    • Marta Hentschke Alterations and association in Endocan-1 and placental growth factor in women with pre-eclampsia
                    • Lutfiya Karimova Genes of vascular tone polymorphism and PE risks in Uzbek population
                    • Natalya Yakovleva Matrix metalloproteinase-12 is a predictor of pre-eclampsia?
                    • Anna Drobintseva Placental kisspeptin and annexin V protein expression in preeclamptic pregnancies
                    • Fabio Barra Incidence of pregnancy induced hypertension (PIH) and small-for-gestational-age (SGA) infants in oocyte-donation (OD) pregnancies: a prospective comparative study
                    • Sapiyat Ibragimova Markers for prediction early and late preeclampsia and fetal development delay
                    • Umida Ashurova Polymorphism of candidate genes associated with the risk of developing gestational hypertension

                    12:00 Friday 9th

                    Affari 0 Sponsored Key Lecture 12:00 ￫ 12:30

                      12:45 Friday 9th

                      Affari 0 Sponsored Key Lecture 12:45 ￫ 13:15

                        13:30 Friday 9th

                        Affari 1 Sponsored Lunch Symposium 13:30 ￫ 15:15

                          Affari 2 Lunch Symposium 13:30 ￫ 15:15
                          Evolution in contraception in 2018

                          Chairperson/s: Santiago Palacios

                          • Rossella E. Nappi Evolution in contraceptive vaginal rings
                          • Illam Baram Evolution in intrauterine contraception

                          15:15 Friday 9th

                          Break

                          15:45 Friday 9th

                          Auditorium Key Lecture 15:45 ￫ 16:15
                          (KL10) Only Estrogen-Only is good for Breast Cancer

                          Chairperson/s: Anne Gompel

                          • Herjan Coelingh Bennink Only Estrogen-Only is good for Breast Cancer

                          Affari 1 Key Lecture 15:45 ￫ 16:15
                          (KL03) Endometriosis and adenomyosis in adolescents, fertile and menopausal women

                          Chairperson/s: John Sciarra

                          • Leila Adamyan Endometriosis and adenomyosis in adolescents, fertile and menopausal women

                          Affari 0 Key Lecture 15:45 ￫ 16:15
                          (KL08) The ovarian renin-angiotensin system

                          Chairperson/s: Jean Michel Foidart

                          • Frederick Naftolin The ovarian renin-angiotensin system

                          Affari 2 Key Lecture 15:45 ￫ 16:15
                          (KL15) Current perspectives on the management of Uterine Fibroids

                          Chairperson/s: Andrea R. Genazzani

                          • Jacques Donnez Current perspectives on the management of Uterine Fibroids

                          Verde Key Lecture 15:45 ￫ 16:15
                          (KL04) Stress, emotional eating, and reproductive function

                          Chairperson/s: Bruno Lunenfeld

                          • Sarah Berga Stress, emotional eating, and reproductive function

                          16:30 Friday 9th

                          Auditorium Symposium 16:30 ￫ 18:00
                          (Symp24) Breast cancer: clinical impact of latest investigations

                          Chairperson/s: Alfred Mueck , Stefanos Zervoudis

                          • Nicoletta Biglia Breast cancer screening today
                          • Anne Gompel When can HT be used in those at increased risk of breast cancer ?
                          • Xiangyan Ruan Membrane-bound-Progesterone-Receptor can predict prognosis of breast cancer
                          • Christian Singer Endocrine therapy and fertility in young breast cancer patients

                          Affari 1 Symposium 16:30 ￫ 18:00
                          (Symp22) Depression and cognition in midlife women

                          Chairperson/s: Michèle Lachowsky , Pauline Maki

                          • Luis Garcia-Segura Estrogenic regulation of neuro-inflammation: implications for depression and cognition
                          • Alessandra Graziottin Osteoarthritis: a neglected trigger of neuroinflammation and depression in women
                          • Tory Eisenlohr-Moul Novel methods for clarifying the psychiatric effects of ovarian steroids across the female lifespan
                          • John Studd Estrogens and testosterone for reproductive depression

                          Affari 0 Symposium 16:30 ￫ 18:00
                          (Symp19) Cardiovascular protection: the sex steroids challenges

                          Chairperson/s: Irene Lambrinoudaki , Peter Collins

                          • Frederick Naftolin Sex steroids block the initiation of atherosclerosis
                          • John Stevenson HRT for primary prevention of CHD
                          • Nestor Siseles Cardiovascular risk in climacteric women: when to begin the hormone treatment ?
                          • Tomi Mikkola Cardiovascular mortality risk and HRT

                          Affari 2 Symposium 16:30 ￫ 18:00
                          (Symp06) Early pregnancy: a critical period with multiple affecting factors

                          Chairperson/s: Tomoyuki Fujii , Mary Stephenson

                          • Takeshi Maruo Thyroid hormone in trophoblast invasion and early pregnancy maintenance
                          • Howard Carp Management of antiphospholipid syndrome in pregnancy
                          • Robert Taylor Gap junctions and hormonal regulation of endometrial decidualization
                          • Mark Brincat The IVF/ICSI, early pregnancy interphase

                          Verde Symposium 16:30 ￫ 18:00
                          (Symp04) Contraception: personalized regimens, new molecules

                          Chairperson/s: Nilson R. De Melo , Angelica Hirschberg

                          • Anna Glasier The advantages and disadvantages of long-acting reversible contraception (LARC)
                          • Johannes Bitzer Do will still need anti-androgenic progestogens?
                          • Adolf Eduard Schindler The role of progestogen-only-pills (POP’s) for contraception and non-contraceptive indications
                          • JEAN MICHEL FOIDART Introducing the first NEST in contraception (native estrogen with selective tissue activity)

                          Affari 4 Oral Presentation 16:30 ￫ 18:00
                          (OP14) Vulvo-Vaginal Atrophy , Bone effects and other Menopause symptoms

                          Chairperson/s: Santiago Palacios , Tobias De Villiers

                          • Emilia Berin Resistance training for hot flushes in postmenopausal women
                          • Simin Taavoni Effect of Valerain Capsules on Menopausal Symptoms: A Triple Blind Randomized Clinical Trial
                          • Sebastian Mirkin Symptomatic vulvar and vaginal atrophy (VVA) relief was achieved with TX-004HR, an investigational vaginal estradiol softgel capsule, with negligible to very low systemic absorption of estradiol: PK comparison with systemic and a vaginal estradiol
                          • Zorana Arizanovic Vasomotor symptoms and blood pressure in menopausal women
                          • Muhammad Fidel Ganis Siregar Relationships of Cognitive Function Based on Informant Questionaire Cognitive Decline (IQCODE) in the elderly with serum estradiol levels on paramedic with menopause age in Indonesia
                          • Thomas Stevenson Effect of HRT on inter-vertebral disc height: data from a prospective randomised trial
                          • Evaggelia Karopoulou Association between calcium metabolism and arterial stiffness in asymptomatic postmenopausal women.
                          • Marta Caretto Effects of six-month oral dehydroepiandrosterone supplementation on beta-endorphin response to oral glucose tolerance test in obese and non-obese pre and postmenopausal women
                          • Ana Osorio Ruiz The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review
                          • Lubov V. Kuznetsova factors affecting the effectiveness of therapy of osteopenic syndrome in postmenopausal women
                          • Svetlana Yureneva Vaginal symptoms and microbiotа in postmenopausal women
                          • Irene Zolfaroli Plasmatic Lipids and bone, the link for new treatments

                          Onice Oral Presentation 16:30 ￫ 18:00
                          (OP15) Pregnancy: gestational diabetes mellitus

                          Chairperson/s: Gary Ventolini , Paolo Mannella

                          • Ofelia Bettikher The vascular reactivity to serotonin of human chorionic plate arteries in gestational diabetes, preeclampsia and both pregnancy complications
                          • Fareha Fauzan Meta-analysis: Genetic Polymorphisms associated with Gestational Diabetes Mellitus
                          • Diana-Elena Comandasu Pregnancy related diabesity and poor fetal outcome: the key role of inflammation
                          • changling DUAN Pregnancy Complications of Polycystic Ovary Syndrome
                          • Salvatore Giovanni Vitale Myo-inositol supplementation to prevent gestational diabetes and effects on body composition in overweight non-obese women: a randomized placebo-controlled trial
                          • Polina Abramicheva Hyperprolactinemia in cholestasis of pregnancy is associated with decreased renal outer medulla Na+/K+-АТPase activity and elevation of pSTAT5
                          • Deng Ao Early risk-prediction models of Gestational diabetes mellitus in Chinese women using support vector machine model
                          • Swati Sharma Evaluation of association of vitamin D insufficiency with gestational diabetes mellitus
                          • Alexandra Onopriychuk Markers of endothelial dysfunction and coagulation in gestational diabetes mellitus
                          • Alexandra Onopriychuk Placental expression of the angiogenic growth factors in gestational diabetes mellitus
                          • Joanna Marie Paulino-Morente Cerebral Cavernous Malformation Activated By Elevated Vascular Endothelial Growth Factor in Placenta, Gestational Diabetes Mellitus, and Hepatic Hemangioma in a Young Pregnant: A Case Report

                          Sala 4 Oral Presentation 16:30 ￫ 18:00
                          (OP16) Endometriosis, DUB and Uterine Fibroids: symptoms and treatments

                          Chairperson/s: Stefano Angioni , Nicola Pluchino

                          • Silvia Baggio Influence of ulipristal acetate therapy on uterine fibroid-related symptoms and on uterine and fibroid volume and vascularity indices assessed by ultrasound
                          • Hugo Maia The Effect of the Association of Miodesin with Gestrinone on Deep Endometriosis Pain
                          • Aleksandar Jurisic What can be expected from Ulipristal in the treatment of uterine fibroids?
                          • Alexandra Mihaila Clinical and paraclinical considerations interesting the hormonal therapy in women with endometriosis
                          • Roxana Matasariu Progesterone treatment in endometriosis- immunohystochemical variations
                          • Roxana Matasariu impact of endometriosis on physical, mental and social wellbeing – a qualitative study
                          • Ticiana Mira What else can we do? A complementary treatment for pain in deep endometriosis using electrotherapy
                          • Arsenii Molotkov Aromatase inhibitors in treatment of endometriosis in experiment and clinical trial
                          • Shara Borgato Uterine fibroids size modifications during pregnancy and puerperium: evidence from the first systematic review of literature.
                          • Giovanni Grandi Dienogest influence on miRNA expression in tumor necrosis factor-α stimulated endometrial stromal cells from women with endometriosis

                          18:00 Friday 9th

                          Auditorium Symposium 18:00 ￫ 19:30
                          (Symp17) Precision medicine and hormone therapy: right woman, right time, right regimen.

                          Chairperson/s: Tomi Mikkola , John Stevenson

                          • Roberta Brinton Diaz The perimenopause is personal: precision hormone therapy to make it precise
                          • Pauline Maki A scientific update on the critical window of hormone therapy and cognition: who, what, when?
                          • Regine Sitruk-Ware How to tailor progestin use to individual needs in the post-menopause
                          • Andrea R. Genazzani How long to treat and how adapt the hormone therapy to the overcoming needs

                          Affari 1 Symposium 18:00 ￫ 19:30
                          (SYMP28) Gynecological symptoms and psychosomatic health

                          Chairperson/s: Tory Eisenlohr-Moul , John Studd

                          • Liliana Gazzuola Rocca Adverse childhood or adult experiences and gynecological symptoms
                          • Tamaki Matsumoto-Takayanagi Autonomic nervous system activity and psychophysiological symptoms during the menstrual cycle
                          • Michèle Lachowksy Endometriosis and infertility, a psychosomatic approach

                          Affari 0 Symposium 18:00 ￫ 19:30
                          (Symp13) PCO: ART and pregnancy outcomes

                          Chairperson/s: Pedro Barri , Luca Gianaroli

                          • Basil Tarlatzis PCOS: what is the preferred stimulation protocol for IVF ?
                          • Xiangyan Ruan Aromatase inhibitors plus HMG for infertile PCOS women
                          • Duru Shah AMH in PCOS and ART outcome
                          • Bart CJM Fauser Metabolic dysfunction in PCOS: implications for pregnancy and children outcomes

                          Affari 2 Symposium 18:00 ￫ 19:30
                          (Symp25) Sexuality all the life

                          Chairperson/s: René Druckmann , Alessandra Graziottin

                          • Johannes Bitzer New sexualities – the internet and sex
                          • Angelica Hirschberg Hormonal contraception and impact on sexuality
                          • Rossella E. Nappi Genitourinary syndrome of menopause and impact on women’s life
                          • Susan Davis Sexual wellbeing and older women- what is the data?

                          Verde Symposium 18:00 ￫ 19:30
                          (Symp08) Progesterone: the life time partner steroid

                          Chairperson/s: Howard Carp , Robert Taylor

                          • Luigi Devoto Different pathways of P-receptor complex in the process of ovulation
                          • Adolf Schindler Prevention or treatment of pregnancy disorders with progestogens
                          • Philippe Bouchard Progesterone: friend and /or foe on breast and CNS
                          • Alfred Mueck Vascular effects of progestogens

                          Affari 4 Oral Presentation 18:00 ￫ 19:30
                          (OP17) Androgen Insensitivity Syndrome and Adolescent Polycystic Ovary Syndrome

                          Chairperson/s: Salvatore Caruso , Zana Bumbuliene

                          • Takhmina Rasuleva LEPR p.Q223R polymorphism influences plasma leptin levels and body mass index in Uzbek obese women of childbearing age.
                          • VERA ANDREEVA The role of Leptin and and soluble Leptin Receptor Levels in pathogenesis of ovarian dysfunction in adolescent girls with obesity
                          • VERA ANDREEVA The role of Toll-like receptors in pathogenesis of insulin resistance and ovarian dysfunction in girls with obesity
                          • Elena Khashchenko Mitochondrial Dysfunction and Oxidative stress activation in Adolescent Girls with Polycystic Ovary Syndrome and Excessive Body Weight
                          • Sujata Kar Metformin versus OCP in adolescent PCOS girls: an RCT from India.
                          • Giulia Gava Bone mineral density in women with complete androgen insensivity syndrome
                          • Mukhlisa Shariksieva The occasion of 21CYP mutation in girls with premature adrenarche
                          • Despoina Apostolaki No Differences in Serum Brain-Derived Neurotrophic Factor between Overweight/Obese and Normal Weight Adolescents with Polycystic Ovary Syndrome
                          • Giovana Maffazioli Evaluation of Reproductive Function in a Rat Model of Genetic Epilepsy Absence Seizures
                          • Vasileios Karountzos The role of Bulimia Nervosa in hormonal and metabolic profile, as well as in menstrual pattern, of overweight and obese adolescents
                          • Mary Grace Villafuerte Mixed Germ Cell Tumor in Androgen Insensitivity Syndrome: A Case Report

                          Onice Oral Presentation 18:00 ￫ 19:30
                          (OP18) Contraception

                          Chairperson/s: David Serfaty , Gabriele Merki

                          • Melinda Vanya Differences in the use of contraception between Roma and non-Roma women in Hungary
                          • Pedro Antonio Regidor Clinical development of Ornibel® a new generation etonogestrel/Ethinylestradiol vaginal ring: Comparative bioavailability and tolerability vs Nuvaring ®
                          • Vitaly Tskhay Results of the operative surgery with severe forms of adenomyosis
                          • Mohd Faizal Ahmad Combined oral contraceptive pills ( COCPs ) versus nsaids in management of bleeding irregularities among implanon users
                          • Pedro Antonio Regidor Clinical development of Ornibel ® a new generation etonogestrel/ethinylestradiol vaginal ring: Comparative tolerability, acceptance and flexibility of the new ring with Nuvaring®
                          • Joanna Kacperczyk-Bartnik Global trends in use of birth control methods
                          • Albe Swanepoel Effect of two ethinyl estradiol and drosperinone containing combined oral contraceptives on whole blood clot viscoelasticity
                          • GIULIA GAVA The impact of counselling and no-cost provision of LARCs in women with repeat abortions in Italy.
                          • Muhammad Azrai Abu Vaginal bleeding irregularities and its perception among implanon users
                          • Aditi Chauhan Sperm impairing factor from Staphylococcus aureus as male contraceptive: An in vivo study

                          Sala 4 Oral Presentation 18:00 ￫ 19:30
                          (OP19) Assisted Reproduction Technologies: from maternal and paternal age impact to ovarian tissue transplantation

                          Chairperson/s: Cesare Aragona , Guido Ambrosini

                          • Maria Costanza Chiti A novel fibrin-based matrix for the creation of an artificial ovary prototype for human application
                          • Patrizia Monteleone Thyroid peroxidase identified in human granulosa cells
                          • Beatriz Alvaro Mercadal Working out the best AMH threshold for a good ovarian response in oocyte donors
                          • Georgios Scheiner-Bobis Physiological and pathophysiological relevance of ZIP9, a zinc transporter, androgen receptor, and G-protein-coupled signal transducer
                          • Sava Micic DNA fragmentation index (DFI) and seminal carnitine, with moderate accuracy, impact progressive sperm motility in oligoasthenozoospermc men treated with metabolic and essential nutrients
                          • Karina Cázarez Pérez Association between advanced paternal age, seminal quality and the dna fragmentation index
                          • Ludmila Barbakadze The value of AMH, AFC and age for prediction of IVF outcome
                          • Diego Daniel Manavella Two-step transplantation with adipose tissue-derived stem cells increases follicle survival by enhancing vascularization in xenografted frozen-thawed human ovarian tissue
                          • Luciana Cacciottola In vivo characterization of metabolic activity and oxidative stress in grafted human ovarian tissue using microdialysis
                          • MacKenzie Purdy Does the co-flare in-vitro fertilization (ivf) protocol change the number of oocytes retrieved for women with diminished ovarian reserve (DOR)?

                          Saturday 10th March 2018

                          08:30 Saturday 10th

                          Affari 1 Meet the Experts 08:30 ￫ 09:30
                          (DEB03) Population Council – ISGE Session: Novel options for women health protection

                          Chairperson/s: Rossella E. Nappi

                          • Regine Sitruk-Ware Vaginal rings for dual protection
                          • Anna Glasier Interventions to reduce unintended pregnancy rates

                          Affari 0 Corso Superiore di Ginecologia Endocrinologica AIGE 08:30 ￫ 11:30
                          (CORSO AIGE03) Endometriosi e dolore pelvico cronico

                          Chairperson/s: Luigi Venturini

                          • Stefano Luisi Le basi fisiopatologiche dell’endometriosi e le scelte terapeutiche
                          • Stefano Angioni Chirurgia dell’endometriosi: quando e quanto radicale?
                          • Antonio La Marca La paziente con endometriosi alla ricerca di una gravidanza: come procedere ?
                          • Alessandra Graziottin Dolore pelvico cronico non da endometriosi : diagnosi e strategie terapeutiche

                          Affari 2 Meet the Experts 08:30 ￫ 09:30
                          (DEB06) Obesity and reproduction: impact in pregnancy and at menopause

                          Chairperson/s: Fabio Facchinetti

                          • Eran Hadar Facing the Non Communicable Disease (NCD) global epidemic – it all starts in utero
                          • Peter Chedraui The metabolic syndrome a pro-inflammatory state before or after the menopause?

                          Verde Scientific Society Symposium 08:30 ￫ 09:30
                          Women in her psychoneuroimmunoendocrinologycal universe – Organized by the Sociedad Argentina de Endocrinologia Ginecologica y Reproductiva (SAEGRE)

                          Chairperson/s: Manuel Noelting

                          • Sandra Demayo PCOS, Insulin- resistant and mood disorder: an intricately overlapped story
                          • Amalia Monastero Stress and the onset of oncological pathologies: the worst oulet
                          • Susana Pilnik Transition to menopause: emotional vulnerability to falling hormones

                          Affari 4 Scientific Society Symposium 08:30 ￫ 09:30
                          New research in Chinese women – Organized by the Chinese Society of Gynecological Endocrinology

                          Chairperson/s: Xiangyan Ruan , Alfred Mueck

                          • Xiangyan Ruan Ovarian tissue retransplantation in cancer patients first center in China
                          • wei huang PCOS with metabolic disorders: Treatment wird insulin sensitizer and lifestyle change
                          • Jinfang Lin Management of PCOS patients with endometrial hyperplasia and early adenocarcinoma

                          Onice Scientific Society Symposium 08:30 ￫ 09:30
                          Unmet needs in sexual care – Organized by the Federazione Italiana di Sessuologia Scientifica (FISS)

                          Chairperson/s: Vieri Boncinelli , Salvatore Caruso

                          • Chiara Simonelli Female genital-pelvic pain disorders
                          • Elena Lenzi Female sexual dysfunctions and couple-based clinical interventions
                          • Salvatore Caruso No drug treatment for women with sexual dysfunction

                          Sala 4 Scientific Society Symposium 08:30 ￫ 09:30
                          Metabolic impact of the climacteric women (Organized by the Chilean Society of Gynecological Endocrinology (SOCHEG)

                          Chairperson/s: Patricio Barriga , Luigi Devoto

                          • Sergio Brantes Clinical responses to the metabolic risk associated with the peri and post menopause
                          • Pablo Lavin Metabolic Syndrome in Chilean women and their oncological risk in breast and endometrium
                          • Marcela Lopez Hormonal and non-hormonal therapeutic strategies to reduce cardiovascular risk in women with high metabolic risk

                          09:45 Saturday 10th

                          Affari 1 Symposium 09:45 ￫ 11:15
                          (Symp31) Menopause: suggestions from nature

                          Chairperson/s: Cuauhtemoc Celis , Ludwig Kiesel

                          • David Archer Novel treatment of vulvovaginal atrophy with prasterone:an approach based upon physiology
                          • James Pickar Novel oral, continuous-combined solubilized 17β-estradiol and natural progesterone provides endometrial protection: Comparison of two randomized controlled trials
                          • Ewald Boschitsch Menopause Hormone Therapy: the natural way is the safest!
                          • Lydia Marie-Scemama Recent international recommandations about HRT: what impact on gynecologists and patients in 2018?

                          Affari 2 Symposium 09:45 ￫ 11:15
                          (Symp11) ART – Time is moving: new difficulties and new possibilities

                          Chairperson/s: Bart Fauser , Joseph Schenker

                          • Luca Gianaroli 40 years after Louise Brown
                          • Paolo Artini Collapse of blastocysts is correlated to implantation success or not ?
                          • Pedro N. Barri Uterine factor in IVF repeated implantation failure

                          Verde Scientific Society Symposium 09:45 ￫ 11:15
                          Hormonal contraception – needs, possibilities and safety: the debate is still going on – Organized by the European Society of Gynecology (ESG)

                          Chairperson/s: Andrzej Milewicz , Mark Brincat

                          • David Serfaty How to reduce unintended pregnancies and abortions
                          • Johannes Bitzer Fertility control among populations living in poverty- an ethical taboo or an urgent necessity?
                          • Ulisse Gaspard Numerous Progestins could be listed as Fourth Generation progestins
                          • Sven Skouby Hormonal contraception: the ghost of pill scare still rides!

                          Affari 4 Scientific Society Symposium 09:45 ￫ 11:15
                          Endocrine disorders during pregnancy – Organized by the Hungarian Society of Gynecological Endocrinology

                          Chairperson/s: George Bartfai , Andras Szilagyi

                          • Attila Jakab Adverse perinatal outcome of pregnancies after ART: twins are responsible for everything?
                          • Szabolcs Várbíró Effect of PCOS and vitamin D deficiency and supplementation on fertility and pregnancy outcomes;
                          • Tamás Deli Effect of endocrine disorders on fertility and fetal and maternal obstetrical outcomes
                          • Imre Kun Tormasi Association of pathological tyrosine isoforms with parameters of hematopoiesis in
                            hyperfiltrating physiological pregnant women
                          • Monika Orosz Hyperprolactinaemia in young women: treatment and follow-up of the infertile patient
                          • Petra Merkely Gender differences in cardiovascular exercise adaptation in a rat model
                          • Szilvia Csehely Laboratory and etiology characteristics of PCOS phenotypes

                          Onice Oral Presentation 09:45 ￫ 11:15
                          (OP20) Polycystic Ovary Syndrome: obesity and metabolic syndrome impact on therapies

                          Chairperson/s: Blazej Meczekalski , Archil Khomasuridze

                          • Moamar Al-Jefout Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
                          • Maria Khmil Benefits of the use of Myo-inositol (FT 500Plus) in women with polycystic ovary syndrome undergoing in-vitro fertilization in antagonist protocols with agonist trigger to prevent the OHSS.
                          • Meeta Meeta Performance of surrogate markers for insulin resistance in women with PCOS
                          • Gokce Anik Ilhan Galectin-3 as a novel biomarker in women with PCOS.
                          • Emma Öberg Improved menstrual function in obese women with polycystic ovary syndrome after behavioral modification intervention – a randomized controlled trial
                          • Valentina Galiano Polycystic ovary syndrome (PCOS): Predictors of response to Metformin treatment
                          • Valeria Versace The resting metabolic rate is not altered in women with polycystic ovary syndrome: a sensewear armband study.
                          • Giovana Maffazioli Evaluation of the Impact of Low L-Carnitine Levels in Metabolic and Hormonal Profile of Polycystic Ovary Syndrome
                          • Giulia Bonelli Classic phenotype of PCOS: does the ultrasound morphology of the ovary associate with the metabolic risk?
                          • Georgina Carranza Escalera Frequency of Fatty Liver Disease in Polycystic Ovary Syndrome patients by phenotype A, B, C and D in the clinic of Endocrine Gynecology of the “Hospital Juárez de México”
                          • Alina Naydukova Prediction of therapeutic effect of metformin in patients with polycystic ovary syndrome
                          • Rodrigo Marcondes Impact of metformin and exercise, isolated or associated, on morphology and oxidative stress in adipose tissue of a polycystic ovary syndrome rat model
                          • Vinicius Cestari do Amaral Effects of estrogen on GLUT4 and IRS1 expression in SGBS-adipocytes

                          Sala 4 Oral Presentation 09:45 ￫ 11:15
                          (OP21) Quality of Life and Sexuality

                          Chairperson/s: Tamaki Matsumoto , Julia Savochkina

                          • Raquel Picó Symptoms and quality of life in women of advanced age as assessed with the mrs scale.
                          • Melinda Bartfai Measuring of quality of life and health characteristics among 40-79 old population in Hungary
                          • Sheryl Kingsberg Bremelanotide (BMT) for Hypoactive Sexual Desire Disorder (HSDD): Efficacy Analyses from the RECONNECT Studies
                          • Linda Vignozzi Psychological and sexual correlates of sexual abuse in women with sexual dysfunction
                          • Linda Vignozzi Psychobiological correlates of vaginismus: an exploratory analysis
                          • mancini ilaria Safety of 5-years testosterone treatment in Female to Male subjects
                          • JOULEN MO-CARRASCAL Abdominal hysterectomy as a risk factor to psychological stress, alteration of sleep and quality of life
                          • Lavinia Domenici Improving Vaginal Health And Sexual Functioning In Gynecologic Cancer Survivors With Probiotics: A Pilot Study
                          • Maria Fernanda Mercado-Lara Comparison of quality of life in climatrics of two colombian ethnics: evaluation with scale cervantes
                          • Angelica Monterrosa-Blanco Insomnia and sexual dysfunction associated with severe deterioration of quality of life in sexually active hysterectomys
                          • Leidy Duran-Mendez Factors associated with sexuality disorders in menopausal colombians
                          • Anastasia Armeni Dopamine receptor D4 (DRD4) gene and brain-derived growth factor (BDNF) gene polymorphisms enhance the impact of estrogen receptor α (ERα) gene polymorphism on female sexuality.

                          11:15 Saturday 10th

                          Break

                          11:45 Saturday 10th

                          Affari 1 Key Lecture 11:45 ￫ 12:15
                          (KL07) Molecular pathways of ageing

                          Chairperson/s: Andrzej Milewicz

                          • Bruno Lunenfeld Molecular pathways of ageing

                          Affari 0 Key Lecture 11:45 ￫ 12:15
                          (KL11) Pituitary adenomas- clinical challenges

                          Chairperson/s: George Creatsas

                          • Joseph Schenker Pituitary adenomas- clinical challenges

                          Affari 2 Key Lecture 11:45 ￫ 12:15
                          (KL06) Significance of estrogens metabolites in the pathophysiology of PCOS

                          Chairperson/s: Sarah Berga

                          • Luigi Devoto Significance of estrogens metabolites in the pathophysiology of PCOS

                          Verde Key Lecture 11:45 ￫ 12:15
                          (KL05) Menopause hormone therapy after 65: available data, risks and benefits

                          Chairperson/s: Frederick Naftolin

                          • Martin Birkhaeuser Menopause hormone therapy after 65: available data, risks and benefits

                          12:30 Saturday 10th

                          Affari 1 Symposium 12:30 ￫ 14:00
                          (Symp30) Post Reproductive Health

                          Chairperson/s: David Archer , Nestor Siseles

                          • Margaret Rees Managing menopause and post reproductive health: beyond hormones and medicines
                          • Cuauhtemoc Celis-Gonzalez Straw and the most frequent co-morbidities
                          • Sandro Scattareggia, Claudia Buzzi, Andrea Giannini The development of an adaptive application to empower women into a healthy life at menopause – the Vita Nova project
                          • Damir Franic Regenerative medicine in post-menopause

                          Affari 0 Symposium 12:30 ￫ 14:00
                          (Symp01) Puberty and adolescence

                          Chairperson/s: Efthymios Deligeoroglou , Charles Sultan

                          • Blazej Meczekalski Kisspeptin role in functional hypothalamic amenorrhea
                          • Camil Castelo Branco Management of transsexuality in an outpatient gynecologic area
                          • George Creatsas Dysfunctional uterine bleeding in adolescence
                          • Vincenzina Bruni Premature ovarian insufficiency therapy in young women

                          Affari 2 Symposium 12:30 ￫ 14:00
                          (Symp09) Vitamin D

                          Chairperson/s: Ulysse Gaspard , Ewald Boschitsch

                          • Faustino Perez Lopez Maternal vitamin D and reproductive outcomes
                          • Andrzej Milewicz Serum vitamine D levels and VDR polymorphisms in women with PCOS
                          • Mark Brincat Vitamin D in PCO and endometriosis. Levels and significance
                          • Yuliya Savochkina Vitamin D level in women with anovulatory disfunction

                          Verde Symposium 12:30 ￫ 14:00
                          (Symp05) Contraception: difficult cases

                          Chairperson/s: Johannes Bitzer , Kristina Gemzell-Danielsson

                          • Rossella E. Nappi Hormonally-related headaches
                          • Nilson R. De Melo Contraception in menopausal transition
                          • Kristina Gemzell Danielsson Contraception for teenagers and young women
                          • Peter Chedraui Contraception in women with cardiovascular risk factors

                          Affari 4 Oral Presentation 12:30 ￫ 14:00
                          (OP22) Assisted Reproduction Technologies: from ovulation induction to luteal phase support

                          Chairperson/s: Patrizia Monteleone , Antonio La Marca

                          • Jean Rouleau Progesterone levels higher than 1,7 ng/ml on the day of hCG are associated with lower clinical pregnancy rates in hcg-triggered gnrh antagonist cycles
                          • Cristina Cossetti Effect of specific nutrients on ovulation, oocytes development, gene expression and coupling success in mice
                          • Fatemehsadat Hoseini A randomized controlled trial of gonadotropinreleasing hormone agonist versus gonadotropinreleasing hormone antagonist in Iranian infertile couples: oocyte gene expression
                          • Shabnam Fayezi Effect of oleic acid on in vitro maturation of oocytes collected from polycystic ovaries and subsequent preimplantation embryonic development
                          • Romualdo Sciorio Blastocysts collapse as an embryo marker of low implantation potential a Time-Lapse study
                          • Hui Long Age related nomogram of serum Anti-Mullerian hormone (AMH) and its prediction of ovarian response in female cynomolgus monkeys undergoing assisted reproductive technology treatment
                          • Sharon Vanetik Day two post retrieval 1,500 IUI hCG bolus, progesterone-free luteal support post GnRH agonist trigger – a proof of concept study.
                          • Hui Lim Does using the combined oral contraceptive pill for scheduling in the GnRH antagonist protocol for IVF/ICSI reduce the pregnancy rate?
                          • Julia Bosdou Subcutaneous progesterone versus vaginal progesterone for luteal phase support in in-vitro fertilization (IVF): a systematic review and meta-analysis
                          • Emina Ejubovic The relationship between the preovulatory and postovulatory progesterone serum concentration and the outcome of the in vitro fertilization
                          • Mohamed Basly Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a Prospective randomised controlled trial (RCT)

                          Onice Oral Presentation 12:30 ￫ 14:00
                          (OP23) Pregnancy and Labour

                          Chairperson/s: Stefano Luisi , Eran Hadar

                          • Michaela dušková Maternal smoking and changes in the fetal steroidogenesis – is there difference due to sex of child?
                          • Diptika Tiwari Detrimental effect of progesterone pathway deregulation modulated immune activation in preterm delivery and outcome in hepatitis e virus (hev) infected pregnancy cases from northeast india
                          • Franzel Alvarez Hott Precocious pregnant teenagers treated in hospital santiago oriente dr. luis tisné brousse: epidemiological profile and perinatal outcomes.
                          • Andrea Sepulveda Perinatal results in premature rupture of fetal membranes in pregnancies under 25 weeks, local experience
                          • Andreas Zouridis Intauterine HPV transmission – a systematic review of the literature and meta-analysis
                          • Muhammad Azrai Abu Is neonatal outcome of the second twin promising?
                          • Chunfeng Yun Prevalence and social factors for birth trauma caused disability among Chinese children: A national survey
                          • Maximilian Brincat A comprehensive literature review on the diagnosis and management of interstitial ectopic pregnancies.
                          • Antonio Simone Laganà Effects of Micronised Dispersible Ferric Pyrophosphate combined with Alpha-Lactalbumin in pregnant women affected by Iron Deficiency Anemia: preliminary results from a prospective, double-blind, randomized controlled trial

                          Sala 4 Oral Presentation 12:30 ￫ 14:00
                          (OP24) Premature Ovarian Insufficiency

                          Chairperson/s: Lydia Scemama , James Pickar

                          • Iulia Potorac Fluctuating primary ovarian insufficiency in a case of type 2 autoimmune polyendocrinopathy
                          • Asma Sassi Premature ovarian Insufficiency: a case report of a particular syndromic association
                          • Svetlana Dragojevic Dikic POI – current hormonal approach in optimizing fertility-the role of melatonin
                          • Anna Szeliga Bone mineral density in patients with premature ovarian insufficiency. The role of hormonal replacement therapy.
                          • Marta Hentschke Is ovulation induction in patients with polycystic ovary syndrome associated with negative maternal outcomes?
                          • Camila Menezes Lima Psychological evaluation in women with premature ovarian insufficiency using Hormonal therapy: depression, anxiety, and stress
                          • Andrea Giraldo Body fat distribution in women with premature ovarian insufficiency on estroprogestative hormone therapy
                          • Helena Giraldo Interferential current: a new treatment for lubrication and dyspareunia complaints in women with premature ovarian failure using hormone therapy

                          14:00 Saturday 10th

                          Affari 1 Closing Ceremony 14:00 ￫ 14:15

                          Register